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ABSTRACT 
One of the oldest, extant, lineages of vertebrates, the sea lamprey, was used to 
clarify the evolutionary origin and divergence of the growth hormone receptor (GHR) 
family. A single, full-length, cDNA, and a second, partial, cDNA were identified and 
shown to encode proteins that share amino acid identity with GHRs and prolactin 
receptors (PRLR s) previously identified.  The complexity of the dynamic signaling 
system, with special emphasis on this system in fish and in the context of the evolution of 
this system, is discussed in the first chapter. The second chapter integrates the new 
insights gained by these studies.  Included is a newly proposed phylogenetic analysis and 
revised nomenclature-system for vertebrate GHRs that better represents the evolutionary 
history of the receptor family. The molecular evolution of the receptors is, furthermore, 
highlighted as the backdrop for the continued discussion regarding how the GH-family of 
hormones exhibit such coordinated and pleiotropic actions.  
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CHAPTER 1. MOLECULAR EVOLUTION AND 
REGULATION OF GROWTH HORMONE SIGNALING: 
TOWARD A HIGHLY INTEGRATED CONTROL SYSTEM OF 
GROWTH 
 
Introduction 
 Although growth hormone (GH) regulates numerous processes in vertebrates, 
including feeding, metabolism, reproduction, osmoregulation, immune function, and 
behavior, perhaps the best studied actions of GH are those related to promotion of 
organismal growth (Forsyth and Wallis, 2002; Bjornsson et al., 2004; Norrelund, 2005; 
Norbeck et al., 2007; Moller and Jorgensen, 2009).  GH results in increased amino acid 
uptake, increased RNA synthesis, increased protein synthesis, increased cartilage 
synthesis, and increased muscle growth (Sheridan, 2011). Many of the actions of the 
growth-promoting effects of GH in fish and other vertebrates are mediated by insulin-like 
growth factor (IGF).  The GH-IGF system has been well studied in mammals and fish, 
and the main elements appear to be highly conserved (Baumann et al., 1988; Reinecke et 
al., 2005).  Circulating GH stimulates the synthesis and secretion of IGF-1 from the liver, 
and IGF-1, in turn, stimulates cell growth and differentiation in a variety of target tissues 
via distinct IGF receptors (Wood et al., 2005; Laviola et al., 2007).  The availability and 
actions of GH and IGF-1 are influenced by GH binding proteins (GHBPs) and IGF 
binding proteins (IGFBPs), respectively (Baumann et al., 1988; Duan and Xu, 2005).  In 
addition, local production of IGF-1 is important, and GH and IGFBPs have direct, non-
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IGF-dependent effects (Butler and LeRoith, 2001; Duan and Xu, 2005; Wood et al., 
2005).  The GH-IGF system of fish is particularly complex, and consists of multiple 
isoforms of GHs, GHRs, IGFs, IGFBPs, and IGF receptors (IGFR) (Reinecke et al., 
2005; Reindl and Sheridan, 2012).    
 Despite extensive knowledge of the GH-IGF system, the molecular basis of the 
pleiotropic nature of GH is not fully understood.   Recent work on the multifaceted GH 
signaling system of rainbow trout Oncorhynchus mykiss and other fish hold promise for 
providing such understanding.  In this chapter, we will review recent findings regarding 
the molecular evolution and structure of GH family peptides and their receptors and 
describe how hormone-receptor interactions selectively activate biological processes, 
with special emphasis on activation and regulation of growth-related processes.  
 
Molecular evolution and structure of GH signaling elements 
 The GH signaling system of the rainbow trout and other species of fish is 
multifaceted, consisting of numerous types of GH-family peptides and a variety of GHR 
subtypes. In this section, the evolutionary origins and the bases of the structural 
heterogeneity of GH-family peptides and the GHR subtypes are described.  
 
Evolution by gene duplication 
 The ancestral salmonids are believed to have gone through several genome 
duplication events. In each case, with a doubling in the chromosome number, salmonid 
species were left with two copies of each gene, some of which could have been 
subsequently lost (Ohno, 1970; Allendorf and Thorgaard, 1984; Hurley et al., 2007;  
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Kuraku et al., 2009; Van de Peer et al., 2009). Over time, however, mutations of the 
remaining duplicated genes would have resulted in structural and functional divergence 
(Konrad et al., 2011). Since these events were the duplication of the entire genome, any 
ligands and receptors present at the time of the event would have been duplicated. Indeed, 
both the GH ligand and GH receptors are believed to have been duplicated during these 
whole genome duplication events (McKay et al., 2004; Liongue and Ward, 2007). 
Furthermore, the family of ligands and receptors, to which GH and GHR belong, are both 
believed to have, long ago, diverged from each other in this duplication-dependent way.  
 In the evolutionary history leading up to actinopterygians (ray-finned fish), three 
whole genome duplication events (1R-3R) are believed to have occurred. The 2R event 
(two successive rounds of whole genome duplication occurred) is believed to have 
occurred early in chordate evolution, perhaps even before the cyclostome-gnathostome 
split (Kuraku et al., 2009). The third of the whole-genome duplication events (3R), also 
known as the fish-specific genome duplication (FSGD) event, is believed to have 
occurred 226–316 MYA (Hurley, 2007; Van de Peer et al., 2009). The 3R event occurred 
in the actinopterygian lineage, which had already diverged from the sarcopterygian (lobe-
finned fish) linage, which included the common ancestor of tetrapods (Meyer and Van de 
Peer, 2005). Thus, for this reason, many fish have two copies of a gene, whereas the 
homologous gene in tetrapods only is found as a single copy. Salmonids, descendants of a 
post-3R common ancestor, underwent an additional duplication event, 4R, which is 
estimated to have occurred 25–100 MYA (Ohno, 1970; Allendorf and Thorgaard 1984). 
In each case of genome duplication, duplicate copies of a gene would result and, at least 
initially, would function fully despite the redundancy. Thereafter, the duplicated copies 
	   4	  
may diverge resulting from non- (pseudo-), neo-, or subfunctionalization (Ohno 1970, 
Innan and Kondrashov, 2010; Konrad et al., 2011).  Other models such as Dosage 
Balance may explain the maintenance of both paralogues (Innan and Kondrashov, 2010). 
Alternatively, over time, genes may have been lost by various events, such as the deletion 
of chromosomal segments containing one or more genes or through gene-by gene events 
such as epigenetic silencing (Sankoff et al., 2012). 
 
Molecular evolution and structure of the GH-family hormones 
 GH is a protein hormone produced by the somatotroph cells of the 
adenohypophysis and is part of the class-I cytokine superfamily, which includes prolactin 
(PRL), the fish-specific somatolactin (SL), and the mammal-specific placental lactogen 
(PL). Additionally, the extra-pituitary production of GH in fish and other vertebrates is 
now well supported, and the extra-pituitary expression of GH genes has been reported in 
trout (Yang et al., 1997a; Harvey, 2010). This protein hormone is evolutionary 
conserved, as it has been isolated from the pituitary of representatives of every extant 
class of vertebrate (Yamaguchi et al., 1989; Kawauchi et al., 2002; Moriyama et al., 
2008).  GH is a single-chain polypeptide roughly 21-22 kDa in size, and shares structural 
similarities with the 22-25 kDa PRL-protein and the 24-28kDa SL-protein (Law et 
al.,1996; Yang et al., 1997a; Li et al., 1997; Wang et al., 2010; Cavari et al., 1995; 
Benedet et al., 2008; Yang et al., 1997b; Yang and Chen, 2003). While GH genes are 
known to contain five exons and four introns in tetrapods, both GH1 and GH2 genes from 
salmonids contain an additional intron, intron E, which interrupts what would otherwise 
be the last, continuously translated exon and thus separates the exon into two exons 
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(Yang et al., 1997a). In general, hormones of this family have four alpha-helical bundles, 
corresponding to four conserved sequence domains that arrange in an anti-parallel 
manner. In order from the N terminal to the COOH-terminal, helices 1-2-3-4 of the hGH 
(human GH) run in an up-up-down-down fashion (de Vos et al., 1992). Members of this 
family of protein hormones bind with members of a distinct family of single-
transmembrane receptors and do so in a somewhat promiscuous way, as these receptors 
have been shown to have varying degrees of affinity among members of this family. The 
actions of these peptides occur upon binding to a dimerized receptor. The presence of 
GHR dimers on the plasma membrane offers an advantage for rapid signaling. Upon the 
binding of a ligand to a receptor dimer, no time is lost as it would be as if a bound 
monomeric-receptor were to require the recruitment of a second receptor for 
dimerization; thus, there is greater potential for the initiation of receptor signaling in 
response to low ligand concentrations, even in cells expressing GHRs at low levels (Gent 
et al., 2002). 
 Evidence suggests that overall salmonid species have two functional, non-allelic 
GH paralogues, GH1 and GH2, that have been retained and their genes are differentially 
expressed at various developmental stages and between sexes (McKay et al., 2004).  The 
coding regions of rainbow trout (rt)GH1 and rtGH2 differ by 22 nucleotides, which 
results in 11 amino acid substitutions in the protein (Yang et al., 1997a). Interestingly, the 
GH1 and GH2 genes are differentially expressed in pituitary glands of trout of different 
ages and sexes (Yang et al., 1997; Chen et al., 1989). Two PRL subtypes, PRL1 and 
PRL2, are believed to have been duplicated in the FSGD, although teleosts appear to 
have retained only a single copy from both PRL1 and PRL2 (Huang et al., 2009). Indeed, 
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two PRLs have been characterized in zebrafish (Danio rerio) although only one has been 
characterized in trout, to date, thus suggesting the possibility that at least one other PRL 
has yet to be characterized in trout (Mercier et al., 1989). Two distinct SLs, with a 56% 
sequence identity, have been characterized in rainbow trout, and these two SL genes 
display a differential expression pattern (Yang and Chen, 2003). Due to the structural 
similarities among GHs, PRLs, and SL(s), binding of PRLs and SLs to the GHR has been 
widely documented in many species of fish, including salmonid species (Zhu et al., 2004; 
Reindl et al., 2009).   
 These ligands are known to have two locations on which they bind to the receptor 
complex, termed binding sites 1 and 2. Extensive structural analysis has been 
accomplished, especially with GH. With a high conservation of structure, a known crystal 
structure of the GH-GHR2 complex from human GH and GHR, and mutational studies, a 
comparative approach can be employed to delineate structural features that are 
particularly important to function. The current model of GHR activation includes the high 
affinity binding of the site 1 of GH to the first molecule of GHR initially, which is 
followed by the binding of site 2 by GH to the second GHR of the dimer (Brooks et al., 
2008). A mutational analysis of GH using domain swapping of goldfish (Carassius 
auratus) GH (gfGH) and goldfish prolactin (gfPRL) also supports a model for a single 
GH with two binding sites bound to a dimerized receptor. The analysis and mutational 
study of goldfish GH supports a model whereby three discontinuous regions on the first 
helix and the region in the middle of the fourth helix comprises binding site 1; the third 
helix appears to be associated with binding site 2 (Chan et al., 2007). While it is believed 
that binding site 1 is involved in the initial, high affinity binding of the first GHR, site 2 
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could be considered more as the functional site that binds the other GHR and determines 
the degree of the rotation of the receptors, relative to each other (Chan et al., 2007; 
Brooks and Waters, 2010; Broutin et al., 2010). This could explain, for example, why a 
lower site 1 affinity for 20-kDa hGH, compared to the site 1 affinity for 22-kDa hGH, 
had nearly the same ability to activate the gfGHR as the 22-kDa hGH (Tsunekawa et al., 
2000), whereas a single steric mutation within binding site 2 creates antagonists, able to 
bind to the receptor, but induce little or no biological activity (Tsunekawa et al., 2000; 
Langerheim et al., 2006). Previous studies with hGH and hPRL have shown that 
mutations in helix 3 of GH and PRL disrupt the integrity of binding site 2, resulting in 
mutants with little or no biological activity but show little difference in ED50 values from 
competitive radioreceptor binding assays (Langerheim et al., 2006; Chen et al.,1994a, b). 
Binding site 2 has been described as the glycine cavity and highlights the Gly and 
surrounding large amino acid residues that, together, create a pocket that a Trp 
(Trp72PRLR or Trp104GHR) from the second of the two receptors in the dimer fill, upon 
binding (Broutin et al., 2010). Variants of hPRL showed that N-terminal mutations 
(which would affect the 3rd helix) also had only a minimal impact on the global affinity 
for membrane receptors (Broutin et al., 2010).  
 Interestingly, for the ligand to bind to the dimerized receptor, it appears that the 
locations of the two binding sites on the ligand are not necessarily as critical as simply 
having two sites with which the two receptors can bind. Dimers and oligomers of GH, 
PRL, and PL which occur through interchain disulfide linkages, linkages between 
glycosylated monomers, or through noncovalent interactions, are found in a relatively 
small portion of the total plasma levels of these ligands in humans; interestingly, dimeric 
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forms of these ligands have been known to exhibit biological activities through the 
normal receptor (Langenheim, 2006). A natural dimeric form of hGH has been shown to 
bind to GHR and PRLR with high affinity and cause unique biological activity in vitro 
(Bustamante et al., 2010; Langenheim, 2006). Interestingly, site-directed mutagenesis at 
the functional binding site 2 of GH creates a GH antagonist with little to no biological 
activity, and when recombinantly engineered into a homodimer does not only maintain 
the ability to bind, but does so through the use of two site 1’s, one from each of the two 
GH antagonists involved in the homodimer. Furthermore, this homodimer, created using 
two antagonists, did not share in the antagonistic effects of the monomers, but instead 
acted as an agonist (Langerheim et al., 2006).  
 Together these studies support that the closely related cognate receptors exhibit 
considerable plasticity in their ability to accommodate various ligands of varying size and 
that, furthermore, the binding characteristics and biological functions of ligands and 
receptors do not necessarily go hand in hand.  The receptors accommodate a ligand 
through two binding sites on the ligand, one which interacts with the first receptor in the 
dimer pair and the second that interacts with the second receptor of the dimer pair; 
tendencies of disruptions between the first ligand binding site and the first receptor affect 
global binding affinities of the receptor for the ligand, while the tendencies of disruptions 
between the second ligand binding site and second receptor affect the functional nature of 
the interaction and may not necessarily show differences in the global binding affinity as 
measured by competitive inhibition studies. Structural features of GH, and comparatively 
of PRL and SL, have important implications regarding the functions of these hormones - 
functions that hinge upon the interactions with their receptors 
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Molecular evolution of GH receptors 
Multiple GHRs derived from distinct mRNAs, believed to be a result of a series 
of gene duplication events, have been described in many species of fish, including 
salmonids species such as masu salmon (O. masou), Atlantic salmon (Salmo salar), coho 
salmon (O. kisutch), and rainbow trout (Fukada et al., 2004; Very et al., 2005; Benedet et 
al., 2008). The use of the terms “GHR1” and “GHR2” for the naming of the multiple 
GHR subtypes was first adopted in the tetraploid salmonids, and this convention 
continued for other teleosts (e.g., Ozaki et al., 2006; Li et al., 2007; Ma et al., 2007). 
Two distinct clades have emerged: GHR type 1 (sometimes written type I) and GHR type 
2 (sometimes written type II) (cf. Saera-Vila et al., 2005, Ozaki et al., 2006), with both of 
the original salmonid GHR1 and GHR2 subtypes contained within the type 2 clade. The 
nomenclature became more complex following the characterization of what appeared to 
be a distinct SL receptor (SLR) from masu salmon based on 125I-SL binding (Fukada et 
al., 2005) that fell within the clade with type 1 GHRs. Recently, Fukamachi and Meyer 
(2007) suggested that all of the teleost type GHR1s should be referred to as SLRs, and 
that the other major clade (type 2 GHRs, which includes the GHR1 and GHR2 of 
salmonids) be referred to as GHRs; they also noted that SLR is a teleost-specific 
paralogue of GHR that arose during the FSGD. The two GHRs of salmonids most likely 
arose during the more recent tetraploidization (4R) event associated with the evolution of 
this group. Reindl et al. (2009) suggested that the binding characteristics observed in 
masu salmon (Fukada et al., 2005) may be a derived trait and that it may be premature to 
assign the label of “SLR” to all type 1 GHRs. Indeed, as will be discussed below, several 
type 1 GHRs retain GH binding characteristics. 
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 Given the confused state of GHR nomenclature, it is clear that a community-wide 
movement towards a simplified nomenclature system that better represents the 
evolutionary history of this receptor family is needed.  To this end, we suggest a change 
to a system similar to that already adopted for instances of multiple genes.  This system 
utilizes different numbers to designate genes derived from one duplication event, then 
different letters to designate paralogues derived from a subsequent round of duplication.  
In application to GHRs, such a system would use numbers to designate the different GHR 
types that arose in the actinopterygian lineage (associated with 3R or FSGD); hence, in 
the teleosts there would be GHR1s (we urge abandonment of the term SLR to avoid 
confusion) and GHR2s. The addition of different letters would be added to distinguish 
paralogues associated with 4R duplication events (e.g., salmonids). This will necessitate 
changes to existing names (and some temporary confusion), but we have already done so 
for our GeneBank designations for trout GHRs. So, what were previously referred to as 
rainbow trout GHR1 and GHR2 (which were both in the type 2 GHR clade), are now 
GHR2a and GHR2b, respectively (cf. GenBank accession nos. NM001124535 and 
NM001124731).  A similar scheme is proposed for the GHR1s.  Whereas salmonids 
appear to have lost a gene following their 4R event and possess a single GHR1 (GHR 1 is 
proposed to be used in preference to SLR so as to avoid confusion and to better represent 
the evolutionary origins of this gene), other species (e.g., Jian carp, Cyprinus carpio var. 
Jian) retained both GHR1 paralogues, designated GHR1a and GHR1b.  For clarity, we 
will use this new nomenclature system for the remainder of this chapter.  
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Figure 1. Phylogentic tree of receptors for prolactin, growth hormone, and 
somatolactin, from fish; GHRs and PRLRs from other vertebrates are included for 
comparison. The tree exemplifies two well-supported receptor clades across the fish 
taxa. The tree was based on the alignment of amino acid sequences using the N–J 
bootstrap method in Clustal X and rooted using the erythropoietin receptor as an out 
group; the tree was visualized with TreeView. Sequences were obtained from either 
GenBank (accession numbers in parentheses) or e! Ensembl (protein ID numbers in 
parentheses) as follows: Atlantic halibut GHR (DQ062814), Atlantic salmon SLR 
(NM001141617), Atlantic salmon GHR1 (NM001123576), Atlantic salmon GHR2 
(NM001123594), black seabream GHR1 (AF502071), black seabream GHR2 
(AY662334), Carassius cuvieri GHR (ADZ13485), catla GHR(AY691178), channel 
catfish GHR (DQ103502), chicken GHR (NM_001001293), Chilean flounder 
(EU004149), cichlid SLR (FJ208943), coho salmon GHR1 (AF403539), coho salmon 
GHR2 (AF403540), common carp PRLR (AY044448), common carp GHR 
(AY741100), eel GHR1 (AB180476), eel GHR2 (AB180477), frog GHR(AF193799), 
gilthead seabream GHR1 (AF438176), gilthead seabream GHR2 (AY573601), 
goldfish PRLR (AF144012), goldfish GHR (AF293417), grass carp GHR 
(AY283778), grouper GHR1 (EF052273), grouper GHR2 (EF052274), Japanese 
flounder (AB058418), Japanese medaka SLR (NP_001098560), Japanese medaka 
GHR (NM_001122905),  Jian carp GHR1a (ADC35573), Jian carp GHR1b 
(ADC35574), Jian carp GHR2a (ADC35576), Jian carp GHR2b (ADC35577), 
lamprey GHR/PRLR (Ellens, unpublished) lungfish GHR (EF158850), masu salmon 
SLR (AB121047), masu salmon GHR (AB071216), Mozambique tilapia PRLR 
(EU999785), Mozambique tilapia GHR1 (AB115179), Mozambique tilapia GHR2 
(EF452496), mrigal Carp (AY691179), Nile tilapia PRLR (L34783), Nile tilapia 
GHR1 (AY973232), Nile tilapia GHR2 (AY973233), opossum GHR 
(NM001032976), orangefin labeo GHR (EU147276), pigeon GHR (D84308), rainbow 
trout GHR1 (JQ408978), rainbow trout GHR2a (NM001124535), rainbow trout 
GHR2b (NM001124731), rainbow trout PRLR (AF229197), rat erythropoietin 
receptor (AAH89810), rat GHR (NM017094), red crucian Carp (ADZ13484), rohu 
GHR (AY691177), southern catfish GHR1(AY336104), southern catfish GHR2 
(AY973231), stickleback GHR (ENSGACP00000023686), sturgeon GHR 
(EF158851), takifugu GHR1 (BAK86396), takifugu GHR2 (BAK86397), Tetraodon 
GHR (ENSTNIP00000004152), tongue sole GHR1 (FJ608664), turbot GHR 
(AF352396), turtle GHR (AF211173), wami tilapia GHR1 (EF371466), wami tilapia 
GHR2 (EF371467), zebrafish GHRa (EU649774), zebrafish GHRb (EU649775). 
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 The phylogenetic relationships of known GHRs are depicted in Figure 1. GHRs 
and PRLRs are believed to have diverged from the erythropoietin receptor (EPOR), thus  
this receptor is used to root the tree. A single GHR/PRLR has been isolated in lamprey 
(Petromyzon marinus) and appears to be the ancestral receptor of both GHRs and PRLRs 
(Ellens et al., 2012).  After divergence from the PRLR, the common ancestral GHR for 
the actinopterygian and sarcopterygian lineages would eventually be duplicated at the 
time of the FSGD event. The current hypothesis regarding the phylogenetic timing of the 
FSGD event is suggested to be sometime after the divergence of the Acipenseriformes 
(represented by sturgeon in Fig. 1) and the Semionotiformes (together considered a 
monophyletic group) from the lineage leading to teleost fish, but sometime before the 
divergence of Osteoglossiformes, the most basal teleost group (Hoegg et al., 2004). To 
date, there is no sequence information for GHR in species representing Seminontiforms 
(e.g., gar) or Osteoglossiformes (e.g., bony tongue). As mentioned earlier, the GHRs of 
salmonids most likely arose during a more recent tetraploidization (4R) event associated 
with the evolution of this group. It appears that many species of salmonids have retained 
both copies of the duplicated GHR2 gene (i.e., GHR2a and GHR2b have both been 
characterized in rainbow trout, coho salmon, and Atlantic salmon). To date, only the Jian 
carp has had two GHR1s characterized, GHR1a and GHR1b (Yuan et al., 2010). 
Interestingly, this variety of carp was artificially developed through integrated genetic 
breeding techniques, using two subspecies of common carp (using Hebao red common 
carp, Cyprinus carpio var. Wuyuanensis, as the original maternal parent and Yuanjiang 
common carp, Cyprinus carpio Yuanjiang, as the original paternal parent). The common 
carp (Cyprinus carpio) is one of two cyprinid species that is believed to have gone 
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through a tetraploidization event, likely independent of the salmonids (Yuan et al., 2010).  
Presumably, one of the copies that resulted from the 4R duplication event in salmonids 
either has been lost or has yet to be characterized. 
 
Molecular structure of the GH receptor family 
 As a member of the type-1 cytokine receptor superfamily, the GHRs have several 
evolutionarily conserved features characteristic of the superfamily: an extracellular 
domain, a single-chain transmembrane domain, and an intracellular domain that consists 
of at least two regions recognized to be important in the mediation of cellular effects that 
occur as a result of the receptor being bound by a ligand (Fig. 2).  Besides the receptors 
for GH (including the fish-specific SL), members of this family include the receptors for 
erythropoietin (Epo), PRL, and the mammal-specific PL, as well as for thrombopoietin, 
leptin, ciliary neurotrophic factor, leukemia inhibitory factor, granulocyte colony-
stimulating factor, and several of the interleukins (ILs) (Bazan, 1990; Carter-Su et al., 
1996). Within this superfamily, GHR is most closely related to the PRLR, EPOR, and the 
PL receptor (PLR). The same duplication event that resulted in paraloguous GHs in trout 
also resulted in duplicated GHR genes. The situation in rainbow trout has been 
complicated by the presence of two paralogous GHRs (GHR2a and GHR2b) as well as 
the one known orthologous GHR1 that has been retained (Very et al., 2005; Walock, 
Kittilson, and Sheridan, unpublished observation).  A single PRLR has been 
characterized in trout (Rouzic et al., 2001).  A second PRLR may remain to be 
characterized. Considering the mechanism by which these receptors are activated, and the 
degree of structural plasticity exhibited by these receptors that allows for such a wide 
	   15	  
degree of binding capabilities, the structure of these receptors is inherently important to 
the resulting biological effects. 
 
 
 
Figure 2. Schematic of the GHR family of receptors: the receptor includes a single 
extracellular domain that can be divided into two structural regions, (sub)domain 1 and 
(sub)domain 2, a single transmembrane domain transverses the cell membrane, and the 
intracellular domain contains two well recognized and conserved domains named box 1 
and box 2. 
 
 Within the extracellular domain, there are numerous features, including conserved 
cysteine residues, a FGEFS motif (the WSXWS motif in other type-1 cytokine receptors), 
and potential N-linked glycosylation sites, which are conserved among these receptors 
and have been recognized to be important for receptor functionality (Fig. 2). The overall 
topology of the extracellular portion of type-I cytokine receptors includes a pair of 
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common beta sandwich motifs resembling fibronectin III/immunoglobulin domains, and 
is referred to by some as a cytokine receptor homology domain (Liongue and Alister, 
2007). The beta sandwich motifs are titled domain 1 and domain 2 by some, and are 
linked by a short segment of the polypeptide chain (Conway-Campbell et al., 2008). 
These two domains of the extracellular GHRs contain roughly 100 residues each. Each of 
the two domains contain seven β strands that together form a sandwich of two antiparallel 
β sheets, one β sheet with four strands and one with three (de Vos et al., 1992).  
  Using the available sequences for the PRLR and GHRs of rainbow trout, we 
constructed the three-dimensional models shown in Figure 3. Based on these models, the 
corresponding extracellular domains (domain 1 and domain 2) of the rainbow trout 
GHR1 and GHR2s, contain six β strands that form the two β sheets. Trout PRLR 
contains 6 β strands in domain 1 and 7 β strands in domain 2 (Fig. 3).  
 Cysteine residues in the extracellular domain are involved in disulfide bonds that 
have numerous important roles including involvement in the folding of the protein, the 
efficiency in the dimerization of the units within the receptor, and the impact the overall 
rigidity of the receptor, as well as the ability of the receptor to bind the ligand. 
Ultimately, the three dimensional shape of the receptor and its rigidity will affect the 
conformational changes that take place to induce cellular effects. In hGHR, there are 7 
cysteine residues, six of which are found in domain 1 of the extracellular portion of the 
receptor (de Vos et al., 1992). Similar to the pattern seen in hGHR, rainbow trout GHR1 
have 7 cysteine residues in the extracellular domain, 6 of which are found in domain 1 
with the last being found in domain 2. In rainbow trout, GHR2a and GHR2b have 5 
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cysteines that are conserved, 4 of which are found in domain 1 with the last, then, found 
in domain 2 (Very et al., 2005). 
 
Figure 3. Receptor models were created using personalized pdb files based on the 
protein sequence of trout GHRs and PRLR. Models were made using SWISS-MODEL 
workspace (Bordoll et. al. 2006; Bordoll et. al. 2009) based on the crystal structures of 
GH-GHR2 (PBD ID: 3hhr; de Vos et. al. 1992) and PRL-PRLR2 (PDB ID: 3ew3; 
Broutin et. al. 2010) and visualized using POLYVIEW-3D (Porollo et. al. 2007). 
  
 Also conserved in the extracellular domain are potential N-glycosylation sites, 
which may be involved in cell surface targeting (Buteau et al.,1998). Five potential N-
glycosylation sites exist in the extracellular domain of each rainbow trout GHR2, two of 
which are highly conserved in vertebrates; these highly conserved sites, in trout 
GHR2a/GHR2b, are found, respectively, at amino acids 140/144 and 188/184 (Very et 
al., 2005). A third potential N-glycosylation site, at amino acid 58/61, is conserved in all 
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fish examined, frog, turtle, and some birds, but is absent in higher vertebrates. Finally, 
located at amino acids 97/101 of trout GHR2s is the last potential N-glycosylation site, 
which is less conserved in fish (found only in salmonids, carp, and goldfish) but is 
conserved in all non-fish vertebrates with the exception of the frog. In the GHR1 
(previously SLR) of Atlantic salmon, only 4 potential N-glycosylation sites are present 
(Benedet et al., 2008); there are 5 potential sites in masu salmon GHR1 (previously SLR) 
(Fukada et al., 2005). Additional information on the single GHR1 that has been isolated 
in trout (Walock, Kittilson, and Sheridan, unpublished observation), will be available 
upon the finalization of its characterization.  
 Domain 1 of the extracellular domain includes the contact region for ligand 
binding. Both of the receptors involved in the dimerized complex, whether in GHR or 
PRLR,  use the same regions to bind GH or PRL (Brooks and Waters, 2010; Broutin et 
al., 2010). These regions of each receptor that in proximity to the ligand is encoded by 
four stretches of sequential amino acids, with each stretch found intermittently on the 
mRNA strand. The correct folding of the protein brings these four regions together to 
create the face that would directly face the ligand and would be directly involved in the 
receptor-ligand interaction. Based on our three-dimensional models of PRLR, GHR1, 
GHR2a, and GHR2b of rainbow trout shown in Figure 3, four sequence stretches that 
make up that face also are present and are indicated by the four colors, cyan, yellow, 
pink, and blue (in order, encoded from the 5’ end of the respective mRNA to the 3’end; 
cf. Rouzic et al., 2001; Very et al., 2005; Walock, Kittislon, and Sheridan, unpublished 
observation).  
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 Upon binding, the resulting conformational structure of each receptor of the dimer 
pair differ, as they would need to in order to adjust their conformation for the binding of 
the diverse and asymmetrically located sites 1 and 2 of GH. Depending on which receptor 
in the dimer receives the binding site 1 of the ligand and which receives the binding site 2 
of the ligand determines which of the receptors in the dimer will take on the differing 
conformational changes, a concept that particularly important if heterodimerization were 
occurring between the GHR types or between the GHR types and PRLR. Indeed, 
preliminary evidence that a functional hPRLR-hGHR heterodimer either exists, or may 
be formed, has been shown (Langenheim and Chen, 2009). The existence and extent of 
heterodimerization between these receptors in fish have not been explored. 
Heterodimerization may certainly influence the relative receptor rotation and 
consequently the alignment of the intracellular domains and have important implications 
in the multi-functionality of GH signaling. 
 Among the different GHRs of rainbow trout, slight differences can be seen, 
especially when comparing the four contact regions of one receptor amongst the 
corresponding four contact regions in the other receptors (see Fig. 3). Although each of 
the receptors in the dimer pair have been modeled individually for this figure, they each 
have been modeled in accordance with one of the two receptors in the dimer of the 1:2 
GH-GHR2 crystal structure (PDB ID: 3hhr). The trout PRLR has been modeled based on 
the 1:2 PRL:PRLR2 crystal structure (PDB ID: 3ew3) Thus, since the receptor is 
essentially able to reconfigure to interact appropriately with the ligand, the 
conformational configurations of the receptors in each dimer pair are reflective of the 
conformational changes that occur upon ligand binding, except that the two receptors 
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would, in reality, be in closer proximity to each other. In hGHR, both fibronectin III 
domains are believed to contribute a key tryptophan residue, in a precise orientation, that 
allows growth hormone to be locked into place through strong hydrophobic interactions 
(Brooks and Waters, 2010).  
 The second of the fibronectin-III motifs, found proximal to the cell membrane, is 
the extracellular domain 2 and contains the receptor–receptor dimerization area. Upon the 
binding of a ligand to the dimer-complex, there is a  rotation of receptor subunits relative 
to one other which results in the locking between the receptor units at the receptor-
receptor dimerization/interaction domain (Brooks and Waters, 2010). Mutations in the 
extracellular dimerization domain disrupt cell surface targeting and signaling without 
altering the binding capacity (Brooks and Waters, 2010; Van Agthoven et al., 2010).  
 Also found in the extracellular domain 2 of these receptors in trout is the FGEFS 
motif; this motif is the homologous WSXWS sequence-motif common of all cytokine 
receptors, which has been implicated to have numerous roles. In humans, this motif is 
seen as YGEFS, whereas in fish this motif is seen as conservative variations of FGEFS 
(Brooks and Waters, 2010; . In salmonids, the FGEFS motif in GHR2s and GHR1s is 
conserved as FGEFS (Fukada et al., 2004; Very et al., 2005; Benedet et al., 2008). It is 
interesting to note that there are some substitutions between GHR paralogues in certain 
species. For example, the first amino acid of this motif in Japanese eel (Anguilla 
japonica) GHR1 is the conserved phenylalanine, whereas the first amino acid of this 
motif in eel GHR2 is alanine (Ozaki et al., 2006). This motif may be involved in 
maintaining the structural integrity of the extracellular domain, and may do so by playing 
a role in the proper folding of the fibronectin motif (Brooks and Waters, 2010). This 
	   21	  
notion was supported by observations that three separate mutations (Tyr222His, 
Glu224Asp, Ser226Ile) in the YGEFS motif of humans resulted in Laron syndrome, a 
condition of growth hormone insensitivity due to the loss growth hormone receptor 
function (Brooks and Waters, 2010). This motif also may be important for receptor signal 
transduction, a possibility supported by a study by Baumgartner et al. (1994) that showed 
that a mutation at the first or final amino acid of the motif affected signal transduction. 
Furthermore, recent work has indicated that this motif is involved in transactivation.  The 
mutation S226A was shown to be transcriptionally inactive (Conway-Campbell et al., 
2008). This serine is conserved as part of the FGEFS motif in the GHRs of fish. Two 
other residues in this consensus motif appear to be unnecessary for transcriptional activity 
because the Y222A (YGEFS) and the E224A (YGEFS) mutants retain full transcriptional 
activity (Conway-Campbell et al., 2008). The significance of these residues may just 
simply fall elsewhere. This motif has also been shown to bind a co-activator and splicing 
protein, co-activator activator (CoAA), in response to the binding of GH; there is 
growing evidence to support that CoAA acts as a chaperone to promote nuclear 
localization of the full-length growth hormone receptor (Brooks and Waters, 2010; 
Conway-Campbell et. al., 2008).  Each of these observations supports the notion that the 
WSXWS motif in cytokine receptors is important for receptor activation (Dagil et al., 
2012).  
 There is tremendous plasticity in these receptors considering the flexibility of the 
conformational adjustments that occur to accommodate various ligands and the ligands’ 
asymmetrical binding sites, and this certainly has implications in the proper alignments 
that are necessary to produce intracellular effects. The single transmembrane domain, a 
	   22	  
characteristic of receptors belonging to the type-I cytokine receptor superfamily, is short 
(19 amino acids long in rainbow trout GHR2a and GHR2b) and plays a major role in 
initiating the presumed ligand-induced realignment of the intracellular domains, which 
leads to the differing intracellular signaling effects. An investigation and modeling of the 
undefined linker region between domain 2 and the transmembrane domain by using Pro 
and Gly substitutions within the linker sequence (13 amino acid long in hGHR) in 
mammals showed that alterations in this linker sequence alters the change in orientation 
of the two linker regions, relative to each other, upon ligand binding; a change in 
orientation would inadvertently change the orientation of the transmembrane helices 
(Rowlinson et al., 2008). Furthermore, the investigators showed that differing ligand-
induced conformational changes in the growth hormone receptors determines the choice 
of signaling pathway. Thus, it seems that the degree with which the ligand can alter the 
extracellular domains of the two GHRs of the dimer thus determines the relative 
movements of these linker regions and consequently, the alterations in the orientation of 
the transmembrane domains and presumably the intracellular domains.   
 Also characteristic of this family of receptors is the presence of numerous tyrosine 
residues, as well as the cytoplasmic Box 1, Box 2, and, more recently revealed, Box 3 
regions in the intracellular domain. Truncation of the membrane-bound receptor, below 
the cell membrane, would presumably alter cell signaling, as well as other functions that 
may be associated with the intracellular domain, such as receptor internalization or 
nuclear translocation as displayed in mammals (Conway-Campbell et al., 2008; Lobie et 
al., 1992); although, no such studies have been conducted in fish.  
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 Intracellular tyrosine residues have been reported to be involved in the GH-
dependent phosphorylation of signal transducer and activator of transcription (STAT) 
proteins (Kopchick and Andry, 2000; Gorisson et al., 2011). The Janus kinase (JAK) 
family of protein kinases is known to phosphorylate STAT proteins. Like the GH-family 
ligands and receptors, the genes encoding these signaling elements have been duplicated 
in the same whole genome duplication events discussed earlier, and a phylogenetic 
analysis by Gorisson et al. (2011) showed that teleostean STATs are orthologues of the 
mammalian STATs, and the teleostean genes that encode them have somehow been 
scattered over their genome. STAT3 and STAT5 and the other STAT family members, as 
most of the classical hormones within the class-I helical cytokine family, such as GH, 
PRL, and EPO, signal predominantly via STAT3 and STAT5, whereas the other 
members of the STAT family serve predominantly in the immune response (Horvath et 
al.,1995; Gorisson et al., 2011). Jak2 in mammals is constitutively associated with the 
GHR and PRLR and is activated by ligands that induce the phosphorylation and 
activation of STAT5 (Kelly et al., 1994; Kopchick and Andry, 2000; Cesena et al., 2007; 
O’Sullivan et al., 2007; Gorisson et al., 2011). The phosphorylated tyrosines in the N-
terminal half of the cytoplasmic domain of rat GHR are believed to be involved in the 
maximal activation of STAT1 and STAT3, in response to GH stimulation and GH-
induced tyrosyl phosphorylation of STAT1 and STAT3 in mammalian GHR is followed 
by the binding of these STATs to the sis inducible element (SIE) of c-fos (Herrington et 
al., 2000).  Interestingly, a heterodimer of ovine GHR and ovine PRLR in living cells 
was demonstrated by fluorescence resonance energy transfer (FRET) microscopy and 
was shown to have prolonged phosphorylation of STAT1 and STAT3 (Biener et al., 
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2003). Surely, the differences in the intracellular domains, including the number and 
location of the intracellular tyrosine residues among the GHRs and PRLs in fish would 
affect signaling although such studies have yet to be reported.  
 The sequence of Box 1 in both trout GHRs is LLPPIPGP. Fish GHRs show only a 
few conservative amino acid substitutions in Box 1. The proline-rich Box 1 motif has 
been shown to be involved in the JAK2-STAT signaling pathway in mammals (Brooks et 
al., 2008; Brooks and Waters, 2010). Until recently, JAK2 was believed to exclusively 
mediate the signaling by the GHR. However, a recent study using transgenic mice with 
mutations in the Box 1 region that disabled 4 proline residues required for JAK2 
activation, found that an inability to activate JAK2 by the GHR does not block its ability 
to activate SFK or pathways that can be initiated by SFK (notably the ERK pathway in 
liver) (Barclay et al., 2010). In Atlantic salmon GHR1, Box 1 shows slight differences; 
LLPPVPAPKIKGI versus the LLPPIPGPKIKGI as seen in the trout GHR2s (Very et al., 
2005; Benedet et al., 2008).  
 The Box 2 motif is a highly acidic/hydrophobic motif that has been recognized to 
be involved in both cell signaling and signal degradation by receptor internalization. In 
addition to the binding of JAK2 to Box 1, JAK2 was shown to bind to Box 2 in mammals 
(Liongue and Alister, 2007). In addition to being involved in signaling, this motif is also 
recognized as the site of recruitment for an ubiquitin conjugation system to the receptor, 
necessary for the ubiquitin-dependent mechanism for GHR internalization (Grovers et al., 
1999). This motif, DSWVEFIELD in humans, is also known as the ubiquitin-dependent 
endocytosis (UbE)-motif for this reason. Upon binding of an active ubiquitin-conjugation 
system to the receptor, the ligand-receptor complex is internalized by the actions of 
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clathrin-coated vesicles; the receptor complex is subsequently transported to lysosomes 
by way of endosomes (Gent et al., 2002).  This motif is homologous to sequences in 
other proteins, several of which are known to be ubiquitinated, including PRLR (Grovers 
et al.1999). The Box 2 motif in trout is DPWVEFIELD (Very et al., 2005); therefore, it 
likely plays roles similar to those in mammals.  
 With the characterization of numerous GHR receptors from a number of species 
of fish, the presence of a third conserved region in the intracellular domain of the GHR in 
fish is now apparent and was pointed out by Di Prinzio et al. (2010) and named Box 3. 
This domain in zebrafish GHR1 (called ghra by the investigators) has the sequence 
DDDSGRASCYDPE, whereas zebrafish GHR2 (ghrb) has the sequence 
DDDSGWASCCDPD.  In rainbow trout, the sequence is DDDSGRASCCDPD for both 
GHR2a and GHR2b (Very et al., 2005). The functional relevance of this domain has not 
been investigated, but the fact that it is a highly conserved, acidic motif of the 
intracellular domain, distal to the cell membrane, suggests a possible role in signal 
transduction.  
 
Sources of variation in GH receptor structure 
 A number of alternatively spliced variants of membrane-bound GHRs have been 
identified in fish and mammals. To date, the presence of alternative transcripts have not 
been examined in trout; however, the presence of fish GHRs with truncated and long 
isoforms of membrane-bound GHRs have been characterized in turbot (Scophthalmus 
maximus) (Calduch-Giner et al., 2001), black seabream (Spondyliosoma cantharus) (Tse 
et al., 2003), and gilthead seabream (Sparus aurata)(Calduch-Giner et al.,2003).  In adult 
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zebrafish, southern blots revealed the existence of two shorter amplification products 
(~500bp and ~700bp) in addition to the 898bp, full-length, GHR1 product. The zGHR2 
also appears to have a shorter, alternative, amplification product; the full-length GHR2 
southern blot fragment is 701bp while this alternative is 450bp. In Jian Carp, different 
jcGHR transcripts were found in the liver; jcGHR 1b' appears to have lost exon 4, 
jcGHR2a'  appears to retain intron 3, which is normally spliced out, and jcGHR 2as has 
lost a portion of exon 8 (Yu et al., 2011). 
 Besides the presence of multiple genes, alternate transcripts or alternative splicing 
of the duplicated GHR genes may be a principal source of differential functioning of 
these receptors as a means to modulate GH actions. In the adult zebrafish transcripts just 
mentioned, the 500bp GHR1-product was expressed in all tissues where the full-length 
GHR1 was amplified, whereas the 700bp GHR1-product was only detected in liver. The 
shorter amplification product of GHR2 was amplified in all tissues where the full-length 
GHR2 product was amplified (Di Prinzio et al., 2010). Interestingly, the presence of 
alternative transcripts of the GHR1 and GHR2 receptors differed during embryonic and 
early larval development, in zebrafish; while there were no observed alternative 
transcripts of GHR1 detected during development, three smaller GHR2 transcripts, in 
addition to the full-length GHR2 transcript, were differentially detected during various 
developmental stages. Southern blot analysis indicated these fragments to be 650, 470, 
and 420bp in size; when recalling that the single alternative GHR2 transcript was 450pb, 
it appears that GHR2 has a total of 4 alternative transcripts that are shorter than the full 
length GHR2 transcript and are differentially expressed throughout the life cycle of the 
zebrafish.  
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 The hGHR is known to have up to 7 different promoters in exon 1 (Waters and 
Brooks, 2011). To date, the genomic organization of GHRs, in fish, have been 
investigated in turbot, gilthead sea bream (Perez-Sanchez et al., 2002), Japanese flounder 
(Paralichthys olivaceus) (Nakao et al., 2004), zebrafish (Di Prinzio et al., 2010), torafugu 
(Takifugu rubripes) (Hirano et al., 2011), and Atlantic halibut (Hippoglossus 
hippoglossus) (Hildahl et al., 2007), although the regulatory elements have not been 
extensively examined in fish. Furthermore, alternative splicing adds to the potential for 
dynamic, tissue-specific, receptor expression; diverse patterns of expression in response 
to variable factors are likely numerable for these receptors. In mammals, for example, the 
expression of exon 1A is known to be “liver specific” in humans, mouse, and rat and 
shows significant differences in expression patterns between the sexes. Besides the 
membrane bound receptor in the liver, exon 1A is expressed in the GHBP transcript 
(Waters and Brooks, 2011). Further studies to characterize the promoter and regulatory 
elements involved in variable receptor expression, as well as establishing the patterns of 
transcript expression and alternative splicing of GHRs and PRLR, in fish and in particular 
trout, are warranted. 
 The presence of a truncated form of GHR known as growth hormone binding 
protein (GHBP), has not been characterized in trout or any other salmonids to date. 
However, previous work by Sohm et al. (1998) showed that a monoclonal antibody to the 
extracellular region of hGHR was able to precipitate a GH complex from the serum of 
rainbow trout, indicating that a truncated mRNA resulting from alternative splicing, a 
proteolytic cleavage event, or a combination of both mechanisms, remains to be 
identified. The production of GHBP by both of these mechanisms has been observed in a 
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wide variety of vertebrate species. The GHBP is well conserved and the development of 
two mechanisms to produce GHBP infers the soluble binding protein is important. The 
production of GHBP by alternative splicing of the full-length GHR gene was reported in 
fish and mammals, including in turbot (Calduch-Giner et al., 2001), Chinese sturgeon 
(Acipenser sinensis) (Liao et al., 2004), and rodents (Smith et al.,1989). The production 
of GHBP by both mechanisms has been reported mammals, including monkey (Martini et 
al.,1997).  In these alternatively spliced GHBPs, the sequence encoding the extracellular 
portion of the receptor differs in just a few base pairs before the hydrophobic 
transmembrane domain; after this divergence in the sequence a short (17-27bp) 
hydrophilic sequence and a divergent 3’UTR, replaces the transmembrane, intracellular 
domain, and 3’UTR of the full length receptor. The hydrophilic tail is encoded by an 
extra exon found between exon 7 (extracellular) and exon 8 (transmembrane), called 
exon 8A. Exon 8A is not known to be present in GHBPs produced by proteolytic 
cleavage (Zhang et al., 2000). The GHBP may have several important roles in the 
modulation of growth. GH bound to GHBP has an increased half-life compared to the 
free hormone (Baumann, 1991a), thus GHBP may represents a hormone-reservoir in 
serum (Baumann, 1991b; Sohm et. al., 1998). GHBP may also act to negatively regulate 
GH actions in several ways: 1) by competing with membrane bound GHRs for ligands, 2) 
by forming GHR-GHBP dimers, resulting in an altered or ablated signaling response, or 
3) by simply down-regulating membrane bound GHR abundance. The production of 
GHBP could be controlled in a tissue specific manner as a means of altering sensitivity to 
circulating GH in a localized manner and, furthermore, could be done in response to 
certain physiological conditions (Sohm et al., 1998). A fourfold increase in the binding 
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capacity of GHBP has been noted to occur 48 h following seawater transfer, suggesting a 
potential role during seawater adaptation in salmonids (Sohm et al., 1998). 
 GHBP has also been shown to be a transcriptional activator. The presence of both 
the full GHR and the alternatively spliced GHBP in the cell nucleus has been reported in 
mammals (Lobie et al., 1992; Graichen et al., 2003; Conway-Campbell et al., 2008). 
Several proteins, relevant to transcriptional activation in the cell nucleus, have been 
found to bind the transcriptionally active GHBP. Two of these proteins include a 
nucleoporin and the coactivator activator (CoAA), which is a transcriptional regulator, in 
addition to an RNA binding-splicing protein (Conway-Campbell et al., 2008). The 
knowledge of the presence of an alternatively spliced GHBP in the nucleus is relatively 
new and has not, thus far, been explored in fish. The presence of an alternatively spliced 
or proteolytically cleaved GHBP in the circulation and in the nucleus of trout warrants 
further studies. 
 Interestingly, numerous reports of metal ion interactions with the type-1 cytokine 
receptors and their ligands have been reported, most notably for zinc. Although zinc is 
not required for the binding of GH or PRL to their receptors, the binding affinity between 
hGH and hPRLBP (extracellular binding domain of the hPRL receptor) was increased 
about 8000-fold by addition of 50 µM ZnCl2 (Cunningham et al., 1990). In this particular 
investigation, the hPRLBP and hGHBP were expressed and secreted into the periplasm of 
Escherichia coli, and binding determined with hGH and hPRL were analyzed. This study 
indicated that [Zn2+] was required for tight binding of hGH to the hPRL receptor but not 
for binding to the hGH receptor. Furthermore, the binding of hGH to hPRLBP, under 
these conditions, is nearly 100-fold stronger than for hPRL and more than 10-fold 
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stronger than the affinity of hGH for one hGHBP (Cunningham et al.,1990). These 
results have been shown to be due to the direct interaction between Zn2+, the hormone, 
and the extracellular receptor (Cunningham et al.,1990;Voorhees et al., 2011). To date, 
the interaction of Zn2+ or any other metal ion with these GH-family receptors has not 
been examined in fish.  
 Overall, there are numerous sources of structural variation in these receptors. 
Structural features of GHR, and comparatively of PRLR, have important implications 
regarding its function, a function that is dependent upon the interactions with ligands in 
the extracellular domain and signaling proteins in the intracellular domain. Modification 
of the structure results in modification of the function and the mechanisms by which this 
occurs are beginning to be defined by accumulating evidence on many fronts. 
 
Differential and overlapping aspects of GH signaling 
 The mechanistic basis that underlies the multifunctionality of GH and the means 
by which target cells adjust their responsiveness to GH to adapt to new environmental 
conditions is unknown.  However, information from studies in trout and other species of 
fish suggests that differential expression of GHR types as well as differential linkages of 
GHR types to cell signaling pathways may play a role.   
 
Differential expression 
 GHR mRNA and protein are expressed in numerous tissues, and although the 
receptor types are often expressed together in these tissues, distinct and differential 
expression patterns are evident. In rainbow trout, GHR2a is more abundant in the brain 
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while GHR2b is more abundant in spleen and pancreas (Very et al., 2005). It is 
interesting to note that there have emerged distinct expression patterns that are apparently 
species specific. In Mozambique tilapia (Oreochromis mossambicus), GHR2 expression 
is highest in muscle, followed by the heart, testes, and liver; whereas, GHR1 expression 
is highest in adipose tissue, liver, muscle, and skin (Pierce et al., 2007). In Nile tilapia (O. 
niloticus), expression of GHR2 is higher, overall, than GHR1 in all tissues except muscle; 
both GHR1 and GHR2 are most highly expressed in liver and muscle. GHR2 expression 
was also high in kidney and stomach, while there was little expression of GHR1 in these 
tissues. In Zanzibar tilapia (O. urolepis hornorum), GHR2 expression was overall higher 
than GHR1 (Ma et al., 2007). GHR2 expression was highest in liver, muscle, and 
intestine while GHR1 expression was high in liver, muscle, and brain. Interestingly, 
GHR1 expression in tissues taken from females was higher than that in tissues from male 
Zanzibar tilapia (Gao et al., 2011). In black seabream, the expression of GHR2 is higher, 
overall, than the expression of GHR1 in many tissues including gonad, kidney, muscle, 
pituitary, and spleen (Jiao et al., 2006).  In gilthead seabream, GHR1 mRNA was highly  
abundant in liver and adipose tissue (Saera-Vila et al., 2005). In zebrafish, both receptors, 
GHR1 (ghra) and GHR2 (ghrb), were predominantly expressed in intestine and liver, 
while also being expressed in kidney, spleen, and ovary; GHR2, but not GHR1, was 
expressed in muscle (Di Prinzio et al., 2010). Expression levels of the four GHRs in Jian 
carp (jcGHRs) were reported and the expression of all four were highest in muscle. 
Differential expression was seen, however; except in brain, jcGHR2b expression was 
higher than the other 3 genes in the remainder of the tissues that were investigated, which 
included liver, heart, head kidney, kidney, intestines, spleen and muscle (Yu et al., 2011). 
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 The differential expression of GHRs occurs in a tissue and species-specific 
manner, which may be indicative of specific adaptations for coordinating growth with 
other physiological processes that are reflective of particular developmental stages in 
unique life histories and in response to variable environmental factors.  For example, the 
pattern of expression of GHR types changes over the course of embryonic development 
(Ma et al., 2007; Raine et al., 2007; Malkuch et al., 2008) and in the face of altered 
nutritional states or osmotic environments (Saera-Vila et al., 2005; Norbeck et al., 2007; 
Pierce et al., 2007; Poppinga et al., 2007).   
 
Differential receptor binding characteristics 
 As mentioned earlier, although trout GHRs bind GH, they also can bind PRL and 
SL. Competitive ligand binding using 125I-GH with CHO-K1 cells expressing rainbow 
trout GHR2a or rainbow trout GHR2b showed that both receptors preferentially bind GH 
over PRL or SL, but GHR2b does so to a greater degree (Reindl et al., 2009). This ligand 
selective binding of trout GHR is diagrammatically represented in Figure 4.  To date, 
there have been few other GHR binding studies in fish.  In masu salmon, SL could not 
displace 125I-GH from GHR 2 (Fukada et al., 2004), whereas GH and PRL were less 
effective than SL in displacing 125I-SL from GHR1 (Fukada et al., 2005), findings that 
prompted the name SLR in salmon instead of GHR1.  There are at least two reasons for 
not using the term SLR to describe GHR1, especially in species other than salmon. First, 
the binding of GH to eel GHR1 could not be displaced by SL (Ozaki et al., 
2006). Second, GH, but not SL, activated both seabream GHR1 and GHR2 transcription 
reporter systems (Jiao et al., 2006; discussed in greater detail below). In the end, it 
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appears that the ability for these ligands and receptors to cross-bind (e.g., GH with PRLR 
or PRL with GHR) and elicit cellular effects in response to cross-binding may be species 
specific.  
 
Figure 4. Model of differential activation of signaling pathways by growth hormone 
receptor (GHR) subtypes: JAK2 activation is essential for propagation of signaling from 
both GHR1 and GHR2 to the ERK, PI3K/Akt, and STAT5 pathways (details of 
pathway elements are omitted for simplicity). Cross-talk occurs between the ERK and 
PI3K/Akt pathways, possibly through Akt activation of c-Raf in the ERK pathway. 
 
GH signal transduction and differential linkage to effector pathways 
 In mammals, GHR is well recognized as utilizing the JAK/STAT signaling 
pathway (Carter-Su et al., 1996; Brooks et al., 2008). More recently, evidence has 
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indicated that GHR also signals via Src-family tyrosine kinases (SFKs), independent of 
JAK2, resulting in the activation of linked extracellular-regulated kinases (ERKs) 1 and 2 
(p44/42) (Brooks and Waters, 2010). The prolactin receptor is also known to utilize both 
the JAK/STAT and the SFK/ERK signaling pathways (Fresno-Vara et al., 2001). SFK 
activation by GH has been shown to be linked to ERK1 (mitogen-activated protein kinase 
3) and ERK2 (mitogen-activated protein kinase 1) through a phospholipase C pathway 
(Brooks and Waters, 2010).  
 Using hepatocytes isolated from rainbow trout, Reindl et al. (2011) examined the 
cellular signaling pathways activated by GH.  GH directly stimulated the phosphorylation 
of ERK, protein kinase B (Akt), a downstream target of phosphatidylinositol 3-kinase 
(PI3K), JAK2, and STAT 5.  Selective inhibitors for JAK2 (1,2,3,4,5,6-
hexabromocyclohexane), MEK (U0126), and PI3K (LY294002), showed that the 
activation of the ERK and PI3K/Akt pathways were depended on JAK2 and that there 
was crosstalk between the ERK and PI3K/Akt pathways (Reindl et al., 2011).  Selective 
inhibitors also were used to demonstrate that GH-stimulated IGF-1 synthesis and 
secretion is mediated through the JAK-STAT, ERK, and PI3K/Akt pathways (Reindl et 
al., 2011). 
 The possibility that the trout GHR types differentially link to cellular effector 
pathways was examined in CHO cells individually transfected with plasmids containing 
the recombinant rainbow trout GHR DNAs.  GHR2a preferentially activated STAT5, 
whereas GHR2b preferentially activated the ERK and Akt signaling pathways (Kittilson 
et al., 2011a).  A model depicting the differential linkage is shown in Figure 4.  Taken 
together with the binding data mentioned above, the activation of a particular signaling 
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pathway appears to depend on the form of GH-family peptide present and on the 
particular GHR subtype (which differs in its affinity to the various ligands)  expressed on 
a target cell.  
  Differential cellular signaling by the multiple receptors has also been shown in 
other species, and there appears to be specific effector system-biological response 
linkages. The biological activities of GHR1 and GHR2 in black seabream (bsb) were 
examined in the presence of seabream (sbGH), salmon GH (sGH), salmon prolactin 
(sPRL), and salmon somatolactin (sSL). In CHO cells expressing bsbGHR1 and 
bsbGHR2, several transcription factors, known in the mammalian GHR gene to be 
activated upon GH stimulation, were shown to be differentially activated in this system. 
The first of these transcription factors, the Spi 2.1 promoter, is activated in response to 
signaling events involving JAK2 (Goujon et al.,1994; Sotiropoulos et al.,1994; 
Dinerstein et al.,1995; Gong et al.,1998). The β-casein promoter, the second of these 
transcription factors, is known to be activated in response to events involving STAT1 and 
STAT5. Finally, the c-fos promoter is believed to be activated upon the induction of 
events involving STAT1 and STAT3 (Smit et al.,1997; Gerland et al., 2000; Jiao et al., 
2006).  
 In cells expressing bsbGHR1, sbGH and sGH could stimulate all three promoters 
(Spi 2.1 promoter, β-casein promoter, and c-fos promoter), whereas sSL and sPRL did 
not induce the activation of any of these promoters (Jiao et al., 2006). In bsb2GHR2, 
sbGH activated the Spi 2.1 promoter and β-casein promoter, but not the c-fos promoter.  
sGH only activated the β-casein promoter, while sSL and sPRL did not activate any of 
the promoters (Jiao et al., 2006). More recently, Chen et al. (2011) showed that neither 
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zebrafish SLα nor zebrafish SLβ could promote GHR1- or GHR2-mediated 
phosphorylation of ERK and Akt.  In addition, whereas zebrafish GH could induce 
promoter activity of the Spi 2.1 promoter, β-casein promoter, and c-fos promoter in cells 
independently expressing zebrafish GHR1(GHRa) and GHR2(GHRb), neither zebrafish 
SLα nor zebrafish SLβ affected promoter activity in GHR-expressing cells. These results 
indicate that interactions of the GHRs with a ligand could induce different biological 
activities, and that this may be the case despite the affinity of the receptor for the ligand. 
However, ligand specificity or affinity could not be deduced by using this approach, since 
binding affinity may not always correlate with the degree of signaling the binding of a 
ligand may induce. 
 
GH signaling and the regulation of growth 
Fish are the most diverse group of vertebrates. They occur in a wide range of 
aquatic habitats including ephemeral streams and lakes, desert springs, open ocean and 
deep ocean trenches up to 9000 m deep), coastal estuaries, and mountain streams and 
lakes (up to 4500 m), and have evolved elegant and often elaborate life history patterns to 
adjust to the conditions present in their environment. Thus, it is not surprising that 
intrinsic (e.g., stage of life history, including sexual maturation) and extrinsic factors 
(nutritional status, temperature, photoperiod, salinity, etc.) modulate the growth of fish 
(Reinecke, 2010; Sheridan, 2011). The integration of such factors in concert with the 
genetic program of the fish, which for many species including rainbow trout enables 
indeterminate growth (Mommsen, 2001), leads to the coordination of growth through the 
interplay of numerous hormones. 
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 As mentioned within the introduction, the primary hormonal control of growth in 
vertebrates is the GH-IGF system.  Much of the research on the regulation of growth has 
focused on the production and release of GH, and there are several recent reviews that 
amply describe the dual antagonistic hypothalamic control of GH release (Canosa et al., 
2007; Chang and Wong, 2009; see chapter by Canosa et al., this volume).  Factors 
produced by the peripheral organs and delivered to the pituitary through the systemic 
circulation also can affect GH release. For example, cortisol, thyroxin, 17β-estradiol, 
ghrelin (which is produced in the stomach as well as the hypothalamus), and leptin can 
stimulate GH release, whereas IGF-1 and somatostatin (which is produced in the gut and 
pancreas as well as in the hypothalamus) inhibit GH release (Sheridan, 2011).  Increasing 
evidence suggests that regulation of growth also involves peripheral controls, including 
“tuning” GH sensitivity and post GHR events as well as modulation of downstream 
events such as IGF sensitivity and action. 
 
A model of peripheral regulation  
 The membrane-bound GHR is a major means whereby growth can be modulated, 
and its actions and regulation in trout have become well documented in recent years. 
Extra-pituitary actions of GH, upon binding to the GHR, can control growth in several 
ways, as shown in Figure 5. GH can indirectly stimulate growth by binding to GHR on 
the liver, inducing the synthesis and secretion of IGF-1 from the liver. IGF-1, in turn, 
stimulates cell growth and differentiation in a variety of target tissues upon binding to 
distinct IGF-1 receptors (IGFR1) (Laviola et al., 2007, Wood et al., 2005, Reindl et al., 
2011). GH may also bind to GHR located on the pancreas, and in this way indirectly 
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modulate growth by the controlled/conditional induction of insulin (INS) (Caruso et al., 
2010; Caruso and Sheridan, 2011).  INS works in concert with GH to promote growth in 
fish; INS deficiency results in growth retardation (Plisetskaya and Duan, 1994). The 
actions of INS to promote growth are many fold.  INS synergizes with GH to stimulate 
hepatic IGF-1 production; and INS deficiency reduces hepatic IGF-1 mRNA levels 
(Duan et al., 1994, Duan and Plisetskaya, 1994).  INS and GH also increase peripheral 
sensitivity to IGF by increasing expression of IGF receptors (Very et al., 2008). Counter 
regulatory feedback mechanisms also operate to inhibit GH-stimulated growth.  These 
include GH-stimulated expression of somatostatin (SS) expression from islet cells 
(Melroe et al., 2004), as well as SS-induced reductions in the expression of INS, GHRs, 
IGFs, and IGFRs (Sheridan and Kittilson, 2004; Hagemeister and Sheridan, 2008; Caruso 
and Sheridan, 2011, 2012).  This system does not monotonically proceed without regard 
to the physiological/developmental state of the organisms, for a constant and 
simultaneous induction of these hormones and their receptors would be futile. In response 
to extrinsic and intrinsic factors, feedback regulatory mechanisms are becoming apparent, 
and seem to be a means of integrating growth with other processes in order to 
appropriately respond to variable factors. The differential expression of GHRs, as well as 
the differential cellular functioning of GHRs, are becoming increasingly clear and are 
emerging as major mechanisms by which this integration can occur, as will be discussed .  
 
GH regulated GHR expression 
 GH has been shown to promote growth, but with somewhat varying efficacy.  
Increased growth responses have been reported in vivo and in vitro for salmonid species, 
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but these seem to vary in degree depending on the species and even upon the strain of 
species. These increased growth responses have been reported in GH-transgenic coho 
salmon and wild-strain, GH-transgenic trout (Ahrens and Devlin, 2011). Since the effects 
of GH are dependent upon the binding of GH receptors, the effect of GH on the 
expression of GHRs is potentially a major mechanism by which these increased growth 
responses occur. Isolated rainbow trout hepatocytes show a 2.5- to 3-fold increase in 
transcription rates of both GHR2a and GHR2b in response to GH treatment (Very and 
Sheridan, 2007). However, it is important to note that the growth response to GH is 
dynamic and species-specific. In comparison to the wild-strain of the GH-transgenic trout 
that showed increased growth responses, the domestic strain of the same species of trout, 
under the same treatment, displayed only a marginal increase in growth (Devlin et al., 
2001). Likewise, a study with GH-transgenic zebrafish, using hemizygous and 
homozygous genotypes, revealed that body mass, GHR and IGF-1 mRNA expression, 
and condition factor were increased in hemizygous fish compared to homozygous fish 
(Figueiredo et al., 2007). In a study with GH-transgenic common carp, there were no 
significant differences in total length, body weight, or condition factor between the GH-
transgenic and non-transgenic genotypes when fed to satiation and reared separately 
(Duan et al., 2011). Also, in vivo treatment of black seabream with seabream GH did not 
alter hepatic GHR2a or GHR2b mRNA expression (Jiao et al., 2006).  
 The differential responses of various organisms to GH may ultimately be due to 
several factors. Certainly, the phenotypic and genetic character of the species or strain 
will put limitations on the responses to GH, a conclusion that logically coincides with the  
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variable structures of the GHRs discussed earlier in this chapter. The extra disulfide bond 
in the extracellular region of trout GHR1, for example, could reasonably limit 
conformational changes necessary for both ligand interactions and subsequent activation 
of cellular activities. 
 
Figure 5. The peripheral-endocrine control of growth in trout, highlights the importance 
of tissue specific responses, which are essentially the key to coordinating growth in 
conjunction with all of the other vital physiological processes. The tissue specific 
expression of GHRs modulates tissue sensitivity to GH, and is a major means of 
coordinating other aspects of the GH-IGF axis. 
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 In a comparative approach, the general growth pattern of a species is genetically 
determined and thus would be a factor to consider when evaluating the effects of GH on 
receptor expression. A slow growing species, such as the wild-strain rainbow trout, and a 
fast-growing species, such as the Jian carp (a common carp variety), would likely 
respond to GH differently. Likewise, GHR expression in response to GH treatment would 
likely not show identical patterns in indeterminate growers, like rainbow trout, and 
determinate growers, like zebrafish. In reality, the expression of the GHRs is not simply 
dependent on the presence or absence of GH at any one moment in time. For example, 
chronic versus acute effects of GH may modulate GHR expression and function. 
Likewise, the simple presence or absence of GH is not exactly expressive of the in vivo 
situation; in reality, variations in the levels of GH, as well as the levels of the GH-family 
ligands which compete with GH for receptor binding, are seen. Differences in the 
evolutionary history of the receptor subtypes and which receptor subtypes have been lost 
or maintained in that species’ evolutionary history is the root determinate of the current 
characteristics of the receptor; the binding affinity and capacity of the receptor subtype 
for the ligand, the presence of the soluble GHBP, and the rate of receptor turnover, and 
receptor interaction with metal ions may all be variables determined by the structure of 
the receptor and are at play in the ultimate control of GH signaling. With unique life 
histories among each species, the genetic background of a species ultimately determines 
the characteristics of all of these factors and their influence on the expression patterns of 
the receptors subtypes, thereby modulating growth.  
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GH as a means of integrating metabolism with growth 
 GH as well as INS and SS have highly defined roles in maintaining metabolism. 
Growth hormone has been shown to be hyperglycemic in several species of fish and to 
increase glycogenolytic, glycolytic, and gluconeogenic flux in several tissues, including 
liver, brain, and gill; these protein-sparing actions of GH are consistent with the soft 
tissue and skeletal growth promoting-actions of GH that prevail when food is available 
(Norbeck et al., 2007). The availability of food, however, is not a constant and 
guaranteed condition for fish in their natural environment. Growth, in situations of fasting 
is stunted, as resources would be shunted towards vital processes and thus, the ability to 
coordinate growth and metabolism in variable conditions is imperative for survival. 
Furthermore, the developmental pattern and life history of an individual species reflects 
natural periods of feeding and fasting. For example, during development the transition 
from alevin to fry is characterized by the movement to the surface of the water where 
they begin to feed. There are also natural differences in food availability patterns between 
species of fish. For example, salmonid fish in northern latitudes experience limited food 
availability during the cold winter months (Pottinger et al., 2003; see chapter by Vargas-
Chacoff et al., this volume).  Likely the most well-known example of natural periods of 
fasting is the home-stream return of salmonids  
 Times of fasting are typically associated with the cessation of growth; 
interestingly, however, plasma levels of GH have been shown to increase in fish and 
other vertebrates during periods of food deprivation. During periods when food is 
unavailable, energy is diverted away from growth to sustain essential metabolic 
processes. During fasting, fish mobilize stored lipid and carbohydrate, and activate 
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gluconeogenesis (Sheridan and Mommsen, 1991). The mechanisms by which GH 
promotes growth (an anabolic process) during periods of food availability yet retarded 
growth and depletion of energy reserves (catabolic process) is yet to be elucidated.  
 Plasma levels of INS increase following a meal and, in turn, INS promotes 
peripheral tissue uptake of glucose and amino acids, and activates synthesis of glycogen 
and triacylglycerols (TG). The postprandial increase in blood glucose is a potent 
stimulator of SS synthesis and secretion in trout (Caruso and Sheridan, 2011).  Insulin has 
been shown to increase the expression of GHR2a and GHR2b (Sheridan, 2010), while 
SS-14 reduces sensitivity to GH in rainbow trout hepatocytes by internalizing surface GH 
receptors (GHRs) and by decreasing transcription of GHR mRNAs (Very and Sheridan, 
2007). 
 Thus, when glucose levels rise in response to feeding, stimulating pancreatic islets 
to secrete INS, an INS-stimulated uptake of glucose into peripheral cells follows. To 
counter the growth-enabling response to INS, SS is simultaneously secreted in response 
to the rising levels of blood-glucose to inhibit INS secretion at which point SS-induced 
glycogenolysis is seen in peripheral tissues (Sheridan and Kittilson, 2004; Nelson and 
Sheridan, 2006). Therefore, the immediate effect of INS to stimulate glycogenesis is 
followed by a counter regulatory-mechanism that together, serves as a homeostatic switch 
between glycogenesis and glycogenolysis.  
 In addition to the regulation of GHR expression, the expression of SS receptors 
(SSTR), IR (INS receptor), and IGFR represent additional important components of this 
peripheral model for the control of growth and coordination of growth with metabolism 
(Fig. 5). An increase of SSTR expression in peripheral target cells occurs in response to 
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INS and GH (Nelson and Sheridan, 2006). Glucose levels further modulate this system 
by regulating both islet and peripheral SSTR expression; increasing concentrations of 
glucose resulted in increased expression of SSTR 2 mRNA in both Brockmann bodies 
and liver (Kittilson et al., 2011b). In the islets, promotion of SSTR expression by glucose 
would enhance islet responsiveness to SS, thereby retarding INS production and blunting 
the growth-promoting and anabolic effects of INS (Caruso and Sheridan, 2011). 
Furthermore,  SS-14 reduces hepatic basal and GH-stimulated IGF-I production of 
rainbow trout, which with increased sensitivity to SS (Very et al., 2008; Hagemeister and 
Sheridan, 2008) would lead to the cessation of growth and activation of observed SS-
stimulated carbohydrate and lipid catabolic processes (Sheridan and Kittilson, 2004) . 
Thus, energy can be partitioned away from growth to meet metabolic demands when 
needed. 
 
Integration of growth with stress and osmoregulation 
 The effects of cortisol on growth in trout and other species of fish remains 
somewhat elusive, as species-specific and condition-specific effects have been observed. 
The duration of post-stress cortisol levels, more so than the levels of post-stress cortisol, 
is correlated with growth rates in rainbow trout; trout with a relatively rapid decrease in 
post-stress cortisol concentrations had a higher rate of growth compared with those that 
had a slower rate of decrease in cortisol concentrations (Weil et al., 2001). However, the 
direct effects of cortisol on gill and liver tissues from rainbow trout were examined in 
vitro and results showed that cortisol increased in both gill and liver tissues, steady-state 
levels of mRNAs encoding GHR2a and GHR2b (Norbeck and Sheridan, 2010). Cortisol 
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also increased hepatic expression of both IGF-1 and IGF-2 mRNAs thus supporting that 
direct effects of cortisol lead to endogenous conditions that would support growth. In gill, 
cortisol also increased levels of IGFR1A and IGFR1B mRNAs thus increasing the 
sensitivity to the cortisol-induced increase in IGF levels (Norbeck and Sheridan, 2010).  
It appears as though these direct effects of cortisol act through the differential modulation 
of GHR expression and, in a theme consistent with growth modulation in this chapter, is 
species specific. In vivo cortisol treatment of black seabream resulted in an increase of 
hepatic GHR1 but not of GHR2 (Jiao et al., 2006). These results indicate that cortisol 
affects growth by modulating the GH-IGF system at several levels, including increasing 
sensitivity to GH, increasing IGF production, and increasing peripheral sensitivity to IGF.  
 The reported cases of both positive and negative effects on growth in response to 
cortisol likely reflect the plethora of environmental conditions (crowding, changes in 
salinity, etc.) that are considered to be “stressors,” as well as numerous physiological 
conditions that could be present at the onset of stress-induced cortisol secretion. 
However, other peripheral hormones reflect these physiological conditions. For example, 
GH, as well as SL and PRL have been reported to be elevated in response to stress 
(Avella et al., 1991; Pottinger et al., 1992; Rand-Weaver et al., 1993; Kakizawa et al., 
1995). 
 Some negative effects on growth in response to cortisol could, potentially, be due to 
indirect effects, such as the modulation of feeding behavior (Volkoff et al., 2009; 
Sheridan, 2011). GH, however, is also known to affect feeding behavior; GH-treated trout 
foraged closer to the water surface, resumed feeding earlier, and ate more food than did 
control trout (Jonsson et al., 1996). These hormones may be dynamically coordinating a 
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balance between feeding behavior and an antipreditor response. Certain developmental 
stages may be set to promote a certain behavior over the other. For example, a situation 
like this would occur in the natural development of trout, as young fry move to the 
surface of the water to feed on aquatic insects.  
 Cortisol and the GH family of ligands dynamically coordinate the transition from 
fresh water (FW) to seawater (SW) of euryhaline fish (McCormick, 2001). The transition 
of juvenile salmonids from  FW streams to the open ocean is a natural part of the their 
life history, and this transfer is associated with increased plasma cortisol and glucose 
levels in cutthroat trout (O. clarkia) parr following a 24 h seawater challenge test 
(Morgan and Iwama, 1996).  It is not known if the interaction of cortisol and GH during 
SW adaptation allows for the channeling of energy away from growth toward 
osmoregulation, but the pronounced stimulatory effects of cortisol on GHR, IGF-1 and 
IGFR expression in gill filaments of trout (Norbeck and Sheridan, 2010) are suggestive. 
 Furthermore, during the marked growth associated with development from fry to 
smolt, physiological preparation for the adjustment to a saltwater environment is 
occurring (Bjornsson et al., 2011). Also during this phase there is a change in coloration 
as the par marks and the brown/green to blue/green colors that were once advantageous in 
the rocky FW streams, fade into a silvery color that would be more advantageous in the 
open ocean (Hoar, 1988). Interestingly, in addition to possible roles in osmoregulation 
and growth, SL is believed to be involved in the development of chromatophores and the 
regulation of pigment (Cánepa et al., 2012). Thus, such dynamic regulation of GH, PRL, 
SL, and their cognate receptors during this life phase of trout is likely the source of 
difficulty in characterizing the roles that each of these hormones play in a single specific 
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process, such as smoltification; it is the coordination of multiple processes that is crucial 
for organismal survival.   
 
Integration of growth with reproduction 
 In rainbow trout, 17β-estradiol (E2) decreased GHR2a and GHR2b expression in 
both liver and muscle, but not in gill, while testosterone increased stead-state levels of 
GHR2a and GHR2b in all three tissues, in a time and concentration-dependent manner 
(Norbeck and Sheridan, 2011). Furthermore, E2 significantly decreased steady-state 
levels of IGF-1 mRNAs in liver and gill, while testosterone significantly increased levels 
of IGF-1 and IGF-2 in liver, and IGF-1 in muscle; there were no significant effects of E2 
on IGFR1 mRNAs in muscle or gill, while IGFR1A and IGFR1B mRNA increased in 
gill, and IGFR1B mRNA increased in muscle, in response to testosterone. Functional 
expression of GHRs, as assessed by 125I–GH binding capacity, was reduced by E2 in liver 
and muscle; however, E2 did not affect 125I–IGF-1 binding capacity in muscle or 125I–GH 
and 125I–IGF-1 binding capacity in gill. In contrast, binding capacity of 125I–GH in liver 
and of 125I–GH and 125I–IGF-1 in both muscle and gill also was increased by testosterone 
(Norbeck and Sheridan, 2011).  
 Again, as a reoccurring theme of this chapter, the modulation of growth appears 
to occur in a species-specific manner. Unlike what is seen in juvenile trout, testosterone 
significantly decreased gene expression of sbGHR2, but not sbGHR1, in liver, whereas 
expression of both sb-GHR1 and sbGHR2 was suppressed by E2 (Jiao et al., 2006). Even 
among salmonids, the modulation of growth is likely to differ to some degree and most 
likely does so in a way that reflects the differences in life history patterns.  For example, 
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semelparous species that typically die after a single spawning event, divert substantially 
more energy into the production of gametes, compared to iteroparous salmonids species 
that may reproduce several times and thus need to energetically maintain physiologically 
processes necessary for survival and for a lifespan that may include several long 
migrations that would include transitions between freshwater and seawater (Johnston and 
Post, 2009). Unfortunately, comparable data on growth-reproduction interactions for 
semelparous and iteroparous salmonids are limited. Although the prevailing hypothesis is 
that sex steroids are the major regulator of programmed death in salmon, hormones 
involved in growth go hand-in-hand with the regulation of sex steroids. In the year before 
spawning, a period of rapid body growth and gonadal development takes place during 
which plasma IGF positively correlates with body size and E2 levels (Campbell et al., 
2006). Increased plasma IGF levels were found in salmon with more advanced gonadal 
development, suggesting that IGF may be involved in linking the timing of body growth 
and sexual maturation in preparation for spawning (Onuma et al., 2010). The integration 
between growth, stress responses and reproduction are integrated and reflect life history, 
and a study by Johnston and Post (2009) exemplifies this well and suggests that life-
history trade-offs differ between the sexes.  
 
Summary and conclusions 
 GH coordinates a vast array of physiological processes, including regulation of 
feeding, metabolism, reproduction, osmoregulation, immune function, behavior, and 
growth.  The multifunctional nature of the hormone arises from a multifaceted signaling 
system consisting of the GH ligand, dimerized type-1 cytokine receptors, and cellular 
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effector pathways.  Interestingly, the GH signaling system of fish displays substantial 
diversity at every level.  For instance, there are multiple forms of GH ligands as well as 
multiple types/subtypes of GHRs.  The structural heterogeneity of the ligands and the 
receptors arises from the existence of multiple genes derived from genome duplication 
events during the course of teleost evolution (the FSGD event ca. 300 MYA; more recent 
independent tetraploidization events in the case of salmoinds and other groups); 
additional heterogeneity of the receptors results from post-translational processing of 
encoded mRNAs. In addition, the GH family of peptides consists of several structurally 
related hormones (e.g., GH. PRL, SL), and in many cases the receptor subtypes display 
promiscuity in binding. Furthermore, the dimerized receptor complexes expressed on the 
surface of cells may be homodimers (e.g., GHR-GHR) or heterodimers (e.g., GHR-
PRLR).  Moreover, GHRs can interact with several cell signaling cascades (e.g., JAK-
STAT, ERK, PI3K/Akt). 
 We suggest that the multifunctionality of GH arises from the diverse, multifaceted 
nature of the GH signaling system. Ultimately, a particular response in a given target cell 
will be determined by the specific interactions between and among the various elements 
of the signaling systems.  For example, by producing and releasing one form of GH over 
another (or by adjusting the relative amounts of other members of the GH-family of 
peptides), the organism can target specific cells which display receptors that are selective 
for that peptide.  The response of the target cell can be modulated by regulating the 
presentation of receptor subtypes presented on the surface of the cell and /or by 
regulating the presence of effect pathway elements to which the receptors link. 
	   50	  
 Evidence is emerging from studies in rainbow trout and other species regarding 
how some of the elements of the GH signaling system are modulated and how such 
modulation affects growth and serves to coordinate growth with other processes such as 
metabolism and reproduction.  For example, nutritional state, insulin, thyroid hormones, 
steroids, including sex steroids, can modulate the sensitivity of targets cells to GH and 
IGFs by adjusting the expression/localization of GHRs and IGFRs and by adjusting the 
actions of GH and IGF-1 in target cells (Figure 5).   
 Our understanding of the GH signaling system, however, is far from complete.  
Although data regarding the differential activation of signaling pathways by some GHR 
subtypes in trout exists (Kittilson et al., 2011a), additional work is needed to gain a 
comprehensive understanding of all GHRs subtypes and whether or not such GHR-
effector pathway linkages are tissue-specific or vary with developmental/physiological 
state.  Fully understanding the multifunctional nature of GH also will require establishing 
the linkages between particular signaling pathways and specific biological responses 
(Figure 4).  Recent work showing that during periods of feeding of rainbow trout, STAT 
and Akt are activated and PLC and PKC are deactivated in tissues, whereas during 
periods of food deprivation,  STAT and Akt are deactivated and PLC and PKC are 
activated, hold promise for resolving the growth-promoting and lipid-catabolic actions of 
GH (Bergan et al., 2012).  Lastly, it also will be important to identify how variations in 
the life histories of fish are reflected in the differences in the GH signaling systems as 
such information will be essential not only for understanding the diversity and evolution 
of GH signaling but for providing insight into agricultural production or conservation of 
species of fish that inhabit diverse aquatic habitats.   
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Objectives of this thesis 
 In the previous decade, receptors for GH, PRL, and SL, had been sequenced in 
numerous vertebrate species, including a plethora of piscine species. As it was found, 
there were multiple genes encoding these receptors, and the naming of these receptors has 
continued to be arbitrary, usually being numbered based upon the order of discovery of 
the homologues in a particular species. This made for a confusing system when using 
comparative approaches because GHR1 in one species and GHR1 of another species 
were not necessarily of the same clade. With the discovery of SL without the discovery of 
a distinct SLR, a change in name of numerous GHRs to SLR was suggested, based on the 
binding characteristics of the receptors in a single species. Thus, the entire evolutionary 
scheme of these receptors was obscured, which inadvertently complicated the study of 
this signaling system and especially complicated the study of this system using 
comparative approaches. A major goal of this thesis, then, was to clarify the evolutionary 
history of these receptors, in vertebrates.  
 Furthermore, with extensive information (e.g., binding characteristics, signaling 
effects) have become available from numerous species, another major goal of this thesis 
was to do an extensive review of the GH signaling system, in fish, to identify the unifying 
themes in the functionality of these receptors, as well as to identify current or potential 
caveats that may be a source for confusion or misguidance that would potentially obscure 
the overall understanding of the physiological effects of this signaling system.  
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CHAPTER 2. EVOLUTIONARY ORIGIN AND DIVERGENCE 
OF THE GROWTH HORMONE/ PROLACTIN/ 
SOMATOLACTIN RECEPTOR FAMILY: INSIGHTS FROM 
STUDIES IN SEA LAMPREY 
 
 Introduction 
 Growth hormone (GH) and the closely related prolactin (PRL) and somatolactin 
(SL) proteins are hormones that have become well known for their multifunctional 
natures. GH, for example, regulates numerous processes in vertebrates, including growth, 
metabolism, reproduction, osmoregulation, immune function, and behavior (Forsyth and 
Wallis, 2002; Bjornsson et al., 2004; Norrelund, 2005; Norbeck et al., 2007; Moller and 
Jorgensen, 2009). Approximately 300 biological actions have been reported for prolactin, 
in vertebrates, with the most well known actions being those involved with the regulation 
of calcium transport in several organs, including gill, intestine, and kidney, and as the 
hormone responsible for the stimulation of milk production in mammals, as well as the 
development of the epithelial lining of the crop-sac that leads to the development of crop-
milk in some types of birds (Wongdee and Charoenphandhu, 2012 ; Kaneko and Hirano, 
1993). The actions of somatolactin, a protein hormone only found in fish, to date, is 
believed to share a relatively recent common ancestor with GH and PRL, and its actions 
also appear to be somewhat diverse. Evidence indicates that SL has involvements in 
metabolism/energy homeostasis and sexual maturation (Vega-Rubín et al. 2004; Rand 
Weaver et al., 1992; Benedet et al., 2008). More recently, evidence has accumulated to 
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give a well-established role, for SL, in the regulation of chromatophore development and 
the movement of pigments in chromatophores; events necessary for environmental 
background color adaptation in fish (Canepa et al., 2012).  More work will be needed to 
delineate the pleiotropic nature of these hormones. 
 These hormones are produced by the cells of the adenohypophysis; GH from 
somatotrophs  and PRL from lactotrophs of the pars distalis, and SL from distinct cells in 
the pars intermedia; although there is no physical distinction between these areas of the 
adenohypophesis in salmonids. Additionally, the extra-pituitary production of GH in fish, 
including salmonids, as well as in other vertebrates is now well reported (Harvey, 2010). 
Extra-pituitary production of PRL has been reported in vertebrates, including fish 
(Imaoka et al., 2010; Ben-Jonathan et al., 1996. Extra-pituitary production of SL has been 
reported in a few species of fish, including rainbow trout (Yang et al., 1997b). GH is a 
single-chain polypeptide roughly 21-22 kDa in size, and shares structural similarities with 
the 22-25 kDa PRL-protein and the roughly 23-24kDa SL-protein (Law et al.,1996; Yang 
et al., 1997a; Li et al., 1997; Wang et al., 2010; Cavari et al., 1995; Benedet et al., 2008; 
Yang et al., 1997b; Yang and Chen, 2003). The crystal structures of GH and PRL show 
that the overall structure of the hormones are a four α-helical bundle, and although a 
crystal structure of somatolactin has not been obtained, sequence comparison supports a 
structural model similar to that of GH and PRL. 
 The biological actions of these hormones occur upon interaction with their 
receptors of which belong to the type-1 cytokine receptor superfamily. Two receptors 
dimerize (receptor1-receptor2) to become the functional receptor complex with which 
these hormones then bind. The membrane-bound receptors of this family are single-
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spanning transmembrane protein, which includes an extracellular domain involved in 
receptor1-receptor2 dimerization and hormone-binding, a single transmembrane domain, 
and an intracellular domain that connects the receptor to downstream effector pathways. 
There are several points of interest regarding the involvement of the receptors in the 
multi-functional nature of these hormones. First, Multiple GHRs derived from distinct 
genes, believed to be a result of a series of gene duplication events, have been described 
in many species of fish, including salmonids species such as masu salmon (O. masou), 
Atlantic salmon (Salmo salar), coho salmon (O. kisutch), and rainbow trout Fukada et al., 
2004, Very et al., 2005, Benedet et al., 2008. For example, three distinct GHRs, able to 
bind GH with resulting receptor activation, have been isolated in rainbow trout Reindle et 
al., 2009).  The consequences of the differential structure of these GHRs on the resulting 
cellular response to hormone stimulation must, reasonably, be explored. Furthermore, 
alternative splicing of any of these GHR genes would result in additional structural 
variants that could, potentially, diversify the GH-GHR signaling response, and indeed, 
the presence of multiple transcripts have been reported in a number of species 
(Baumbach et al., 1989; Calduch-Giner et al., 2001; Edens and Talamantes et. al., 1998; 
Martini et al., 1997; Tse et al., 2003; Di Prinzio et al., 2010). These structural variants 
could modify the physiological response of these hormones in several ways: 1) by 
altering the receptor-ligand affinity, 2) by altering the overall structure of the receptor 
enough that the conformational-change that occurs as part of the mechanism of receptor 
activation is altered, 3) by altering the intracellular domain to result in altered cell 
signaling, 4) by creating competition between expressed receptors, for the ligand, and 5) 
by, theoretically, creating heterodimers with divergent functional properties from 
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homodimerized receptors of which these receptors are assumed to be . Besides multiple 
structural variants for which GH can bind, a second important point of interest regarding 
the receptors’ involvement in the multi-functionality of GH, would be the differential 
expression of these multiple structural variants in a single cell/tissue, as well as the 
differential expression of the structural variants among different tissues.  
 In the past decade, thanks to advancements in sequencing, numerous GHR-family 
mRNAs and several GHR-family genes have been characterized in a plethora of fish 
species as well as in numerous species of tetrapods, while additionally, the publication of 
several genomes databases allowing for predictions regarding genes and proteins, has 
occurred. Furthermore, the crystal structures of several complexes between GH and PRL 
bound to monomeric and dimeric forms of their receptors have been solved. Combined, 
this valuable information now provides a means by which various comparative strategies 
to explore the origins of the multi-functionality of these hormone-receptor systems can be 
employed. The overall objective of this study was to enhance our understanding of the 
polygenic origins of GHRs and to provide insight into the linkage between GHR subtype 
and physiological response. To this end, we have characterized a protein with 
characteristic features of a type-1 cytokine receptor from sea lamprey (Petromyzon 
marinus); we believe the gene encoding this protein is the evolutionary-precursor to both 
the GHRs and PRLRs thus far characterized in the vertebrate lineage.  
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Materials and methods 
 
Experimental animals  
 Liver tissue for an adult lamprey was used to obtain and characterize the GHR 
mRNA. Three sexually mature adult male lampreys were used to obtain RNA used in the 
tissue distribution study. Finally, cDNAs were obtained from S.A.S., as pools of samples, 
of various tissues, from both male and female lampreys. These cDNAs were used in the 
tissue distribution study.    
 
RNA extraction 
Tissue was homogenized using RNAzol RT (Molecular Research Center, Inc., 
Cincinnati, OH, USA). Water was added to the homogenate and protein and DNA 
precipitation was accomplished by centrifugation of the contents at 12,000g; DNA 
precipitate was discarded. The remaining supernatant containing the RNA was isolated 
and transferred to a new microcentrifuge tube. mRNA precipitate was isolated by adding 
75% Ethanol followed by centrifugation at 12,000g for 8 minutes. The supernatant was 
removed and discarded and the pellet containing the precipitated RNA was washed twice 
with 75% ethanol. Ethanol was removed and the pellet was dried.  The RNA was re-
hydrated in RNase-free water. Immediately after isolation of total-RNA, oligo dT beads 
from the GenElute™ mRNA Miniprep kit (Sigma-Aldrich, St. Louis, MO, USA) were 
used to isolate mRNA.  
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Oligonucleotide primers and probes 
 Gene-specific primers used for isolation of cDNAs were designed by examining 
known GHR sequences using GeneTool software (BioTools, Inc., Edmonton, AB) and 
custom synthesized by Sigma-Genosys (The Woodlands, TX, USA).  Additional primers 
for reverse transcription were provided in the SMARTER™ RACE cDNA Amplification 
Kit (BD Biosciences Clontech, Palo Alto, CA, USA).  Gene-specific oligonucleotide 
primers and probes used for real-time PCR of GHR were designed using ABI Primer 
Express® Version 2 software, based upon the sequence of our determined GHR 
sequence. Primers and probes were used for reverse transcription and PCR without 
further purification. 
 
Isolation and characterization of putative GHR-like mRNA 
 A three-phase approach was adopted for the isolation of a GHR-encoding cDNA 
using reverse-transcription (RT)-PCR and rapid amplification of cDNA ends (RACE)-
PCR.  Isolation of the cDNA sequence was accomplished using the SMARTER™ RACE 
cDNA Amplification Kit (BD Biosciences Clontech, Palo Alto, CA, USA) following the 
manufacturer’s protocol.  In phase I, RNA from rainbow trout liver was reverse 
transcribed into cDNA containing the sequence tags necessary for SMARTER™ 
chemistry, and remaining cycles of PCR were carried out using a gene-specific (5’-
GCCCGGATTACGTCACTGC-3’) primer designed for 3’RACE. Products amplified 
were then identified by electrophoresis on an agarose gel containing 1% of each OmniPur 
(EMD chemicals, Gibbstown, NF, USA) and NuSieve GTG agarose (Bio-Wittaker 
Molecular Applications, Rockland, ME, USA) in 1 x Tris-borate-EDTA (TBE) buffer 
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followed by ethidium bromide staining. The product of this first reaction was combined 
with a nested primer (5’-CGGCAAACACGTCCTTCGAG-3’), designed internally from 
the original 3’RACE primer, in second reaction to reamplify the correct fragment of 
interest and reduce the background and nonspecific amplification seen with the first 
primer. The products of this second reaction were then visualized as described 
previously. The PCR products were then cloned into the pGEM-T Easy Vector (Promega, 
Madison, WI, USA) and inserted into JM109 cells.  Purified plasmids (75 fmol) were 
sequenced using the CEQ 2000 Dye Terminator Cycle Sequencing with Quick Start Kit 
(Beckman Coulter, Fullerton, CA, USA) according to the manufacturer’s protocol.  
 After determining that the initial PCR reaction resulted in a unique cDNA with 
reasonable sequence identity with known GHR-encoding cDNAs, phase 2 consisted of 
two independent PCR reactions, the first with a unique set of primers (Forward, 5’-
GTGCCGGACGGTGGACAT- 3’; Reverse, 5’-TGCGCTCGTCGTCCGTCTCTCACC-
3’) and the second with another unique set of primers (Forward, 5’-
CTGCTGGCGTGATGACATT- 3’; Reverse, 5’-GGCCCCGCAGTGACGTAAT-3’) 
Initial attempts at 5’RACE, immediately after obtaining sequence from phase 1, were 
unsuccessful; thus, these PCR reactions (phase 2) allowed us to obtain more sequence, 
extending off the known 3’end of the mRNA, so that new gene-specific primers could be 
designed for 5’RACE. The PCR products were visualized, cloned into the pGEM-T Easy 
Vector, and sequenced as described previously. To confirm that the sequence gathered 
from phase 1 and phase 2 could, indeed, be assembled as a single product, a forward 
primer (5’-CTGCTGGCGTGATGACATT- 3’) and a newly designed reverse primer (5’-
TTGCACCATATCGACATTCAGAA-3’) were used for a “confirmation PCR” reaction. 
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The PCR products were visualized, cloned into the pGEM-T Easy Vector, and sequenced 
as described previously. 
 After obtaining the additional sequence, in phase 2, new gene-specific primers 
were designed and used in phase 3, 5’RACE. 5’-RACE was performed using a 
SMARTER™ RACE cDNA Amplification Kit under manufacturer’s suggested 
conditions with the GHR gene-specific primer (5’-GCAGACTCGTTCGCCAGGG-3’) 
designed for 5’RACE.  The resulting PCR products were visualized, cloned into the 
pGEM-T Easy Vector, and sequenced as described previously. 
 
Real-time PCR assay; quantification of GHR-encoding mRNA 
Preparation of cDNA standards: 
 cDNA standards for were synthesized by PCR.  Approximately 1 µg of the 
RACE-ready cDNA product was used as template for PCR with forward and reverse 
gene-specific primers under the same conditions as described previously (Slagter et al., 
2004).  The resulting PCR products were visualized under ultraviolet light, cloned into 
the pGEM-T Easy Vector, and their sequences verified, as described previously. 
Real-time reverse transcription PCR:  
 Previously purified mRNA, the endogenous poly(A)+ RNA was reverse 
transcribed in a 10 µL reaction using AffinityScript QPCR cDNA Synthesis Kit 
(Stratagene, La Jolla, CA, USA) to the manufacturer’s instructions. Reactions without 
reverse transcriptase were included as negative controls; no amplification was detected in 
negative controls. 
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 Real-time PCR reactions were carried out for samples, standards, and no-template 
controls in a 10 µL reaction; each reaction contained 1 µL cDNA, 1 µL each of forward 
primer, reverse primer and probe at concentrations optimized for the mRNA species to be 
measured, 1 µL RNase-free deionized water, and 5 µL Brilliant II SYBR® Green Low 
ROX QPCR Master Mix (Agilent Technologies®, Santa Clara, California, U.S.A.)  The 
primers used were, (Forward, 5’-TGCACGCAAGTGTTTCTTCCT-3’; Reverse, 5’-
GGGAGGCTGCAAATGTCATC-3’) were designed to be gene specific.  Cycling 
parameters for real-time PCR were as follows: 95 oC for 10 min, and 45 cycles for 95 oC 
for 30 s plus 59 oC for 1 min.  
 Copy number calculations were based on threshold cycle number (CT).  The CT 
for each sample was determined by the MX3000P™ real time analysis detection software 
after manually setting the threshold. Sample mRNA expression (copy number) was 
determined by relating CT to a standard curve comprised of serial dilutions of known 
amounts of lamprey GHR/PRLR cDNA. Copy numbers of mRNA were considered non-
significant if CT exceeded 45 cycles; this value corresponds to a detection limit of less 
than 100 mRNA copies. 
 
Data analyses 
 The nucleotide and associated protein sequences were aligned and analyzed with 
GeneTool and PepTool sequence analysis programs, respectively (BioTools Inc., 
Edmonton, Alberta, Canada). TM-COFFEE, a program specifically designed to align 
transmembrane proteins using homology extension, was used (with default settings) to 
produce the alignment necessary for determining the conserved regions of the protein, as 
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well as the phylogenetic tree; the tree was visualized with TreeView and rooted to the rat 
erythropoietin receptor. Potential phosphorylation sites (either protein kinase A or protein 
kinase C) were predicted by NetPhos 2.0 (default settings).  A signal peptide was 
predicted using the SingnalP 4.0 server, set a default settings for eukaryotes.  
 Quantitative data are expressed as means ± S.E.M.  Statistical differences were 
estimated by a cell means model ANOVA followed by Duncan’s multiple range test; a 
probability level of 0.05 was used to indicate significance.  All statistics were performed 
using SigmaStat v. 1.0 (SPSS, Chicago, IL, USA). 
 To produce a predicted 3-dementional depiction of the protein, predicted from the 
obtained mRNA sequence, SWISS-MODEL (a protein structure homology-modeling 
server) was used to produce unique protein data bank files (.pdb files), based upon the 
amino-acid sequence of interest and upon a chosen target protein. human GHR (pdb ID: 
3hhrB and 3hhrC) was used as the template structure for the homology modeling of the 
extracellular domain of the lamprey GHR-like protein, as well as for the trout GHRs. Rat 
PRLR (pdb ID: 3npzB and 3npzC) was used for the predication of the trout PRLR model.  
 
Results and discussion 
 
Characterization of GHR-like mRNA 
  A cDNA fragment, 1115 bp in length (including the poly-A tail), was amplified 
by phase 1 (3’RACE) of the previously described approach. Sequence analysis suggested 
the successful isolation of a fragment of a GHR/PRLR-like protein. Initial attempts at 
5’RACE with primers designed from this cDNA fragment, however, were unsuccessful. 
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With the lamprey genome database available, we were able to circumvent the problem by 
designing forward primer based on a location of the scaffold that was predicted to be 
coding (exon) region. The reverse primer for PCR was designed based on the initial 
cDNA fragment we had obtained. The resulting cDNA obtained was 365 bp in length and 
overlapped with the cDNA fragment obtained in phase 1.  A second PCR reaction using 
this approach (a forward primer based on predicted exon-region and a reverse primer 
based on isolated sequence) resulted in a second fragment that was 230 bp in length and 
overlapped, considerably, with the first of the PCR fragments from phase 2.  The final 
phase, phase 3, of our approach consisted of 5’RACE PCR, using a gene-specific primer 
designed from sequence previously obtained. Figure 1 illustrates the 3-phase approach 
and the assembly of resulting fragments.  
 The three-phase approach, utilizing both RACE-PCR and traditional PCR, yielded 
a 1729 bp cDNA with an open reading frame encoding a coding region 249-amino acids 
in length (Fig. 6).  Sequence analysis of the coding region revealed the successful 
isolation of the extracellular domain, but showed an absence of both the transmembrane 
domain and intracellular domain, explaining a shorter mRNA length than predicted (GHR 
mRNAs are typically about 2500-3000bp in length, in most fish). Upon further 
investigation, it appeared that the isolated protein was consistent with a soluble hormone 
binding protein produced by alternative splicing of the gene. The protein has a single 
signal peptide cleavage site was estimated to be between pos. 48 and 49. Furthermore, 
examination of the structure reveals a protein that includes an intact hormone-binding 
interface, which presents as being homologous to the hormone-binding interface of full-
length GH receptors. An additional result of 5’RACE was a second mRNA fragment that 
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was nearly identical to the other 5’RACE fragment except that this second fragment 
included additional sequence that did not assemble with the fragments from phase 1 and 
phase 2. The additional fragment is identical to DNA sequence that is part of the same 
contig as the other fragments isolated, thus supporting the notion that this additional 
segment is alternatively spliced (Fig. 6e shows the alignment of this alternative fragment, 
with the other fragments isolated in the 3-phase approach).
 
Figure 6. Three-phase approach to the characterization of sea lamprey GHR/PRLR 
mRNA. Agarose-gel electrophoresis, a. phase-1, b. phase-2, c. phase-3, and schematic 
representations, d. assembly of overlapping PCR-fragments yeilds a full-length, 1711-bp, 
transcript encoding a truncated GHR/PRLR and a separate, 473-bp, GHR/PRLR splice 
variant. e. alignment of the sequences obtained, illustrating sequence-gaps that 
distinguish the two obtained variants.   
 
 The sequence, overall, is similar to the sequences of both characterized GHRs and 
PRLRs, and exhibit conserved features that are characteristic of this family of receptors. 
This family of receptors has several conserved cysteine residues, two of which are 
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conserved in GHRs, but are not present in PRLRs or in the type-2 GHRs. Indeed, the 
characterized lamprey sequence exhibits these cysteine residues, except for the two that  
are not present in PRLRs nor in the type-2 GHRs, but are present in the type-1 GHRs. A 
modeled prediction of the lamprey GHBP, which will be discussed in more detail in a 
later section, reveals the structural conservation of subdomain 1 of the extracellular 
domain; this subdomain contains the interface for hormone binding. Subdomain 2 of the 
extracellular domain of the lamprey protein is truncated just before the FGEFS motif that 
is characteristic of GHRs in fish (homologous to the WSXWS motif in other type-1 
cytokine receptors). However, much of the area of subdomain 2, is present in the lamprey 
sequence. The WSXWS domain is believed to be involved in the mechanism that 
transduces activity resulting in cell signaling involving the intracellular domain; thus, the 
exclusion of this motif in a soluble binding protein would be inconsequential to this 
protein’s ability to function as a binding protein. 
 Subdomain 2, of the extracellular domain contains the dimerization domain, or 
stem-stem interface (region of interaction between the two receptors of the dimer), of the 
receptor. Furthermore, this area is also important in the rotation of the receptor-pair, 
relative to eachother, that occurs during receptor activation (van Agthoven et al., 2010). 
It is thought that the conformational rotation that occurs to activate the receptor results in 
downstream signal transduction by shifting the alignment of the “linker region,” the short 
region found in the extracellular domain, just before the transmembrane domain, which 
subsequently realigns the transmembrane domain thus altering the alignment and 
conformation of the intracellular domain (Rowlinson et al., 2008). Mutations in the linker 
region support this theory, with altered ratios of ratio of STAT5 to ERK1/2 signaling 
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(Rowlinson et al., 2008). Recently, the characterization of the dimerization interface, also 
known as the stem-stem interface (or site 3), of the PRLR has been completed, and upon 
comparison with the GHR, even though the general region of the dimerization domain is 
common between the two, the actual interface is different in in PRLR and GHR (van 
Agthoven et al., 2010).   
 Tissue expression of the characterized lamprey mRNA was surveyed in numerous 
tissues and its expression quantified. Results show (Figure 8) that the characterized 
mRNA is widely distributed among tissues, a characteristic consistent with the 
pleiotropic nature of the GH/PRL signaling system that is transduced through their 
receptors. Furthermore, differential expression is seen among the tissues, with the highest 
expressions seen in the pituitary and liver, a result that reflects GHR expression patterns, 
reported for liver and pituitary, in other species. High expression of the GHR is typically 
also seen in muscle; however, liver has been reported to be the major source of GHBP in 
other species (Ross et al., 1997; Carlsson et al., 1009). Thus, this result further supports 
the prediction that the characterized protein is indeed the GHBP.   
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Figure 7. The cDNA and deduced amino acid sequences of truncated GHR/PRLR (seq 1) 
and a GHR/PRLR 5’ splice variant (seq 2) isolated from sea lamprey. The predicted 
hormone-binding regions are boxed in color (region 1=magenta, region 2=cyan, region 
3=green, region 4=blue); the predicted dimerization domain is boxed in gray; and 
possible phosphorylation sites,  denoted by       .  The position of putative splice sites is 
indicated by   .   
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 In general, GHBP is well conserved, as the production of GHBP by multiple 
mechanisms has been observed in a wide variety of vertebrate species, inferring that the 
soluble binding protein is, physiologically, important. The first-discovered GHBPs were 
found to be produced through proteolytic cleavage of the extracellular domain from the 
membrane-bound receptor (Leung et al., 1987; Baumann et al., 1988). Later, it was found 
that an alternative means of production GH binding proteins can also occur through the 
alternative splicing of the gene that, also, encodes the full-length receptor (Edens et al., 
1994). The production of GHBP by alternative splicing of the full-length GHR gene was 
reported in fish and mammals, including in turbot (Calduch-Giner et al., 2001), Chinese 
sturgeon (Acipenser sinensis) (Lioa et al., 2004), and rodents (Smith et al., 1989; Edens 
et al., 1994; Edens et al., 1998; Baumbach et al., 1989; Talamantes and Ortiz, 2002), to 
name a few. The production of GHBP by both mechanisms, in a single species, has been 
reported in mammals (Martini et al., 1997).   
 
	   91	  
Figure 8.  Distribution of GHR/PRLR mRNA among tissues in adult sea lamprey.  
Expression of mRNA was evaluated by real-time PCR.  (A) Qualitative expression was 
assessed by separating PCR amplicons (after 45 PCR cycles) on agarose visualized by 
ethidium bromide staining and transillumination. mRNA expression was quantified by 
determining the threshold cycle number (CT) for each sample from its amplification plot, 
as exemplified for liver (B). Sample copy number was then determined by relating CT to 
a standard curve (C) comprised of a serial dilution of a known amount of lamprey 
GHR/PRL cDNA, then normalized to β-actin and (D) expressed as mean±SEM (n=4-6).  
Groups with different letters are significantly different (p<0.05). 
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 Interestingly, alternative splicing of the GHR gene have been found to produce 
distinct mRNAs that encode other “truncated receptors,” besides the soluble GHBP. In 
humans, alternative splicing of the GHR can produce a membrane bound receptor lacking 
the entire intracellular domain that is seen in the full-length receptor, and instead exhibits 
6 intracellular amino acids that are novel, after the transmembrane domain and before the 
stop codon; another truncated receptor that is still membrane-bound, in humans, was 
shown to maintain the majority of the full-length intracellular domain, but lacks the 
intracellular portion encoded by exon 9; the joining of exon 8 and 10, then, creates a 
frame shift that results divergent sequence and an alternative stop codon (Ross et al., 
1997). A second truncated hGHR was found to be missing 26 amino acids of exon 9 in 
which case a frameshift encoding an alternative amino acid sequence results in a 
premature stop codon, thus truncating the majority of the intracellular domain (Ross et 
al.,1997; Dastot et. al, 1996). The partial deletion of exon 9, in this truncated receptor, 
resulted from a cryptic splice acceptor consensus sequence (Ross et al, 1997; Dastot et al 
1996). Besides the soluble GHBPs produced by alternative splicing, it appears that most 
of the truncated receptors that have been characterized result in a receptor with an altered 
intracellular domain. However, in several human prostate cancer cell lines, an expressed 
truncated receptor was found to be missing exon 3, which encodes the N-terminal portion 
of the extracellular domain to result in a receptor that is 22 amino acids shorter in length 
and that has an unknown physiological relevance (Chopin et al., 2002). Alternative 
splicing has also been found to be responsible for a long form of the growth hormone 
receptor, in Black Seabream, that includes an additional alternative splice site not 
characterized in any other organism (Tse et al., 2003). This long form of GHR includes 
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an additional 33 amino acid segment in the intracellular domain that does not result in a 
frameshift to cause any other differences in the intracellular domain.  Alternative splicing 
of the PRLR gene has also been found to produce multiple transcripts, including both 
truncated and long-forms of membrane bound PRLRs (Tanika et al., 200)  
 Although evidence of GHBPs and alternative transcripts of membrane-bound 
receptors have been noted in a few fish species, complete genome organization and the 
actual characterization of GHBPs, or other truncated GHRs that are produced by 
alternative splicing, are generally lacking in fish. This is potentially important 
information that would need to be obtained for a full understanding of numerous 
processes, such as growth. Alternative transcripts can work in numerous ways to affect 
physiology. The soluble binding proteins, for example, can increase the half-life of the 
hormone, act as a hormone-reservoir, or create competition with the membrane-bound 
receptors, for the hormone. The alternative membrane-bound receptors may also have 
various functions. For example, truncated GHR, even those that have had the majority of 
the intracellular domain lost can still dimerize with a full length receptor inhibit cell 
signaling (Ross et al., 1997). Furthermore, an understanding of alternative splicing, 
especially since it appears to be highly conserved in the GHR system, would be an 
important in the understanding of disease. The altered expression of alternative 
transcripts, in tumorigenic or carcinogenic tissues, have been reported in numerous 
studies (Tan et al., 2011). To note, it has been concluded that a significant fraction of 
point mutations that result in human genetic disease disrupt splicing (Krawczak et al. 
1992, Faustino and Cooper, 2003).  
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Evolution of GHRs 
  Figure 9 depicts the phylogenetic relationships of known members of the 
GHR/PRLR family, with emphasis on the GHRs characterized in fish, and includes the 
characterized GHR-like protein characterized in this paper. Although we understand that 
any analyses that come from this phylogenetic tree are tentative, as only the extracellular 
portion of the lamprey receptor could be included, the tree is, non-the-less, helpful in 
predictions. As before, the analysis reveals two distinct clades, for the GHRs: type-1 and 
type-2. Furthermore, the lamprey appears as an intermediary, between the PRLR clade 
and GHR clades, which is consistent with our prediction that Lamprey GHR/PRLR-like 
receptor is the evolutionary precursor that gave rise to both PRLRs and GHRs. The 
pattern that emerges from this analysis is consistent with the structural features of these 
receptors, which will be discussed in the next section. 
 First, it is important to clearly identify the evolutionary relationship of these 
receptors to ease comparative approaches to the understanding of receptor functioning at 
the molecular level. To further explore the relationships of these GHRs, in fish, a 
qualitative microsyntany survey (Figure 10) was performed. While the complete 
assembly of sequence and chromosome mapping has yet to have occurred in most species 
of fish, several sequence databases and BAC libraries have made it possible to search for 
genes and manually align contigs in a small number of fish species. Unfortunately, there 
is insufficient information in the lamprey genome to include this species in the analysis. 
In the analysis, a selection of candidate genes, known to be within close physical 
proximity to the GHR genes, were mapped in a number of species. As seen in Figure 10, 
there is differential patterning of these syntenic regions that is consistent with the two-
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clade (type-1 and type-2 GHRs) conclusion of the phylogenetic analysis and that, 
furthermore, supports an orthologous relationship between the type-1 GHR and hGHR.  
The descent of GHRs in fish and Sarcopterygians from a common ancestor is supported 
by the juxtaposition of C7 near the GHR locus (except Coelacanth, the genome of which 
is incomplete and data on the location of C7 is not available).  The duplication and 
divergence of teleost GHRs also is reflected in their synteny maps. Multiple genes retain 
their position near the GHR locus, including PLCXD3, C5orf51, FBX04, SEPP1, and 
ZNF131, in humans as compared to the Type 1 GHR genes of teleosts; however, other 
genes near the locus of GHR1 in teleosts, such as IP011 and OXTCT2, were moved to 
other locations in humans. The transposition of C6 and C7 in humans also is interesting 
to note. Genes such as PIP5K1B and TJP2 are only near the Type 2 GHR locus in teleosts 
and were moved to other locations in humans. Interestingly, the CCDC152 is positioned 
near the Type 2 GHR locus of teleosts and retained its juxtaposition near the GHR locus 
in humans. For some of these species, especially those that have sequencing projects in 
early stages (e.g., salmon) the absence of any one of these candidate genes, is not 
necessarily indicative of its true absence in the species, but is likely a gene we could not 
annotate by the manual alignment of the contigs/scaffolds. Despite some of the 
limitations, the global analysis still supports a conclusion consistent with that of the 
phylogenetic tree and with the previous analysis by Fukamachi and Meyer: teleost GHR1 
and GHR2 are paralogs that arose through gene duplication, and that teleost GHR 1 and 
GHR2 are orthologs to Sarcopterygian GHR (as evidenced by humans). In summary, two 
distinct clades have emerged among the GHRs, type-1 and type-2, with the type-1 GHRs 
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having and orthologous relationship to the linage of GHR that gave rise to tetrapod 
GHRs. 
 
Structural assessment of the family of receptors for GH, PRL, and SL 
 With a clearer understanding of the evolutionary relationships between these 
receptors, comparative approaches to the assessment of the molecular basis of 
functionality can more easily be employed. Two regions of these receptors will be 
examined in detail: the dimerization domain, and the hormone-binding domain. Sequence 
alignments and 3-dimential predictions of structures will be used to support a deeper 
understanding of the molecular basis of functionality.  
 Since an altered alignment of GHR dimerization domain residues could alter 
degree of rotation of the GHR transmembrane domains to result in altered cell signaling, 
as discussed earlier, the dimerization domain is clearly an important region to examine 
the molecular basis of the receptor functionality and how that may be transduced into the 
physiological functions of these species. Figure 11 shows an alignment comparing the 
homologous regions of the dimerization domain from characterized PRLR and GHR, in 
fish species, as well as in a handful of tetrapod species. Indeed, clear patterns are seen 
between the receptor types (clades) and can even be seen between groups of closely 
related species. In the GHR complex, most of the interacting residues are part of the 
initial Leu-Gln172 region (human GHRas the reference), while most of the interacting 
residues in the PRLR interface are part of the latter domain region, which in human 
PRLR stretches from Lys-His197. Although the characterized regions of the crystal 
structures for GHR and PRLR used as the reference are from human (GHR) and rat  
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(PRLR) frame, with no structural reference frame available from a species of fish, 
conservation of several residues, found to be interacting residues in the human and rat 
receptor interfaces, is seen. For example, Asn161, Ser163 and Asp170 (hGHR) are 
involved in hydrogen bonding at the hGHR dimerization interface. These residues are 
highly conserved among the GHRs, in the species shown; while Asp is perfectly 
conserved in all GHRs, Asn and Ser are almost perfectly conserved in the type-1 GHR 
clade, while some substitutions are seen in the type-2 clade. To note, these Ser and Asp 
residues are also present in the characterized lamprey sequence. Looking, again, at the 
initial stretch that is highly involved in the GHR-GHR interface, and comparing the 
equivalent area for PRLR, the characterized rPRLR is two residues shorter and is 
therefore unable to get involved in the PRLR-PRLR interaction. This absence at the 
interface allows the two PRLR subdomain 2s to get closer than the two GHR subdomains 
(van Agthoven et al., 2010).  The structural differences between the two receptors in a 
ligand-bound dimer, and between the receptor types (GHR1a, GHR1b, GHBP, PRLR) 
can be seen in Figure 12. Although it is not possible to completely predict the 
dimerization interfaces in these receptors without a crystal structure, the presence of a 
residue gap in the PRLRs, and not in the GHRs, is a conserved feature and suggests that, 
like in the hGHR, this stretch of the dimerization domain is likely involved in the GHR-
GHR interactions. Interestingly, this stretch of the lamprey sequence has features similar 
to both the GHRs and the PRLRs; a two-residue gap is present, however, the sequence 
Asn-Val-Ser (Asn and Ser being involved in H-bonding at the GHR-GHR interface) that 
is present in hGHR, but not PRLR, is present in the lamprey sequence.  
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Figure 9. Phylogenetic tree of the known growth hormone receptors (GHR) of fish and 
selected other vertebrates.  Prolactin receptors (PRLR) from selected teleosts are included 
for comparison. The tree was based on the alignment of amino acid sequences using the 
N–J bootstrap method in Clustal X and considered only completely overlapping segments 
greater than 300 nt in length.  The tree was rooted using the erythropoietin receptor as an 
out group and was visualized with TreeView.  The branch lengths represent amino acid 
substitutions per site from a common ancestor and are proportional to the estimated time 
since divergence occurred.  The nomenclature for a particular receptor reflects that given 
by the authors originally or that which appears in databases; if the sequence was not 
annotated or the receptor type/subtype was not specified, the designation on the tree is 
ours and was chosen for consistency with the phylogenetic analysis and our proposed 
nomenclature. We recommend abandonment of the term somatolactin receptor (SLR), 
and the use of letters to designate GHR subtypes in teleosts. Sequences were obtained 
from either GenBank (accession numbers in parentheses) or Ensembl (protein ID 
numbers in parentheses) as follows: Atlantic halibut GHR (DQ062814), Atlantic salmon 
GHR1 (NM001123576),  Atlantic salmon GHR2  (NM001123594), Atlantic salmon SLR 
(NM001141617), black seabream GHR1 (AF502071), black seabream GHR2 
(AY662334), Catla GHR (AY691178),  Channel catfish GHR (DQ103502), chicken 
GHR (NM_001001293), Chilean flounder GHR1 (EU004149), Coelacanth GHR 
(ENSLACG00000005546), coho salmon GHR1 (AF403539), coho salmon GHR2  
(AF403540), common carp GHR (AY741100), common carp PRLR (AY044448), frog 
GHR (AF193799), gilthead seabream GHR1 (AF438176), gilthead seabream GHR2 
(AY573601), goldfish GHR (AF293417), goldfish PRLR  (AF144012), grass carp GHR 
(AY283778), Japanese crucian carp GHR (ADZ13485), Japanese eel GHR1 
(AB180476), Japanese eel GHR2 (AB180477), Japanese flounder GHR (AB058418), 
Japanese medaka GHR (NM_001122905),  Japanese medaka SLR (NP_001098560), jian 
carp GHR1a (ADC35573), jian carp GHR1b (ADC35574), jian carp GHR2a  
(ADC35576),  jian carp GHR2b (ADC35577), lamprey GHR/PRLR (this sequence),  
lungfish GHR (EF158850), masu salmon GHR (AB071216), masu salmon SLR 
(AB121047), Mozambique tilapia GHR1(AB115179), Mozambique tilapia GHR2 
(EF452496), Mozambique tilapia PRLR (EU999785), Mrigal carp GHR (AY691179), 
Nile tilapia GHR1 (AY973232), Nile tilapia GHR2  (AY973233), Nile tilapia 
PRLR(L34783), opossum GHR  (NM001032976), orange spotted grouper GHR1 
(EF052273), orange spotted grouper GHR2  (EF052274), orangefin labeo GHR 
(EU147276),  pigeon GHR  (D84308), rainbow trout GHR1 (JQ408978), rainbow trout 
GHR2a (NM001124535), rainbow trout GHR2b (NM001124731), rainbow trout PRLR  
(AF229197), rat erythropoietin receptor  (AAH89810), rat GHR GHR (NM017094), rohu 
labeo GHR  (AY691177), South American cichlid SLR (FJ208943), southern catfish 
GHR1 (AY336104), southern catfish GHR2  (AY973231),  stickleback GHR 
(ENSGACT00000023732), sturgeon GHR (EF158851), Takifugu GHR1 (BAK86396), 
Takifugu GHR2 (BAK86397), Tetraodon GHR  (ENSTNIP00000004152),  tongue sole 
GHR1 (FJ608664), turbot GHR (AF352396),  turtle GHR (AF211173), wami tilapia 
GHR1 (EF371466), wami tilapia GHR2 (EF371467), Wuchang bream GHRa 
(AFC38427), Wuchang bream GHRb (AFC38428), yellowfin seabream GHR2 
(AEW29012), zebrafish GHRa (EU649774), zebrafish GHRb (EU649775).                  
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Figure 10. Synteny maps of growth hormone receptor (GHR) loci and the genes flanking 
them in humans and fish.  Horizontal lines represent partial chromosomes/ scaffolds/ 
groups/ contigs with species name listed on the left and the chromosome/ scaffold/ group/ 
contig number and size listed on the right for each line; gene positions are relative and are 
omitted for clarity; The 5’-3’ orientation of each gene, when known, is indicated by >.  
Colored boxes on the lines represent genes that were manually annotated as follows: 
GHRs and teleost type 1 GHRs (yellow), teleost type-2 GHRs (dark green), C5orf28 
(cyan), C6 (blue), C7 (red) CCDC152 (pink), PIP5K1B (green horizontal strip), TJP2 
(red vertical strip), IP011 (green diagonal strip), OXCT (red vertical strip), PLCXD3 
(purple), C5orf51 (orange), FBX04 (dark blue) SEPP1 (bright green), ZNF131 (teal). 
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 Another region that can be examined at the molecular level to reveal trends 
generally consistent with the phylogenetic analysis is the ligand-binding interface, also 
termed site 1 (site of binding between the first receptor and hormone) and site 2 (site of 
binding between the second receptor and hormone). This region is important considering 
the current model of GHR activation, which includes the high affinity binding of GH to 
the first of the receptors of the GHR dimer, initially, and  is followed by the low-affinity 
binding of GH to the second GHR of the dimer (Brooks et al., 2008). A mutational 
analysis of GH using domain swapping of goldfish (Carassius auratus) GH (gfGH) and 
goldfish prolactin (gfPRL) also supports a model for a single GH with two binding sites 
bound to a dimerized receptor. The analysis and mutational study of goldfish GH 
supports a model whereby three discontinuous regions on the first helix and the region in 
the middle of the fourth helix comprises binding site 1; the third helix appears to be 
associated with binding site 2 (38). While it is believed that binding site 1 of the hormone 
is involved in the initial binding of the first GHR (GHR1), in which case the hormone has 
a conformational change while GHR1 does not have a major conformational change, site 
2 of the hormone could be considered more as the functional site that binds the second 
GHR (GHR2), determinging the degree of the rotation of the receptors, relative to each 
other (Chan et al 2007; Brooks et al 2008; Broutin et al., 2010); GHR2 goes through a 
conformational change to, essentially, accommodate the binding of GH. Thus, since this 
binding induces this conformational change (rotation of receptors, relative to eachother) 
that results in signaling, differing degrees of conformational change which could happen 
if different ligands are binding (e.g., SL binds GHR versus GH binding GHR) may likely 
result in differential signaling in the cell. 
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Figure 11.  An alignment of regions known to be involved in the dimerization of 
GHRs or of PRLRs. Human GHR and human PRLR are the reference sequences; lines 
appearing below or above resdues indicate strict conservation of the reference-residue 
in the non-human GHR or non-human PRLR sequence, respectively. The symbols  
and  indicate a residue that has been conserved between the lamprey sequence and 
human GHR or the lamprey sequence and the human PRLR, respectively. Dashes (-) 
represent gaps that were inserted to maximize alignment; * denote missing sequence. 
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Figure 12. Three-dimensional models of the extracellular domains of the truncated 
growth hormone receptor (GHR)/prolactin receptor (PRLR) from sea lamprey (center) 
and of the GHRs and PRLR from rainbow trout. Receptor models were created using 
personalized pdb files based on the protein sequence of trout GHRs and PRLR; these 
were made using SWISS-MODEL workspace (Bordoll et. al. 2006; Bordoll et. al. 2009) 
based on the crystal structures of GH-GHR2 (PBD ID: 3hhr; de Vos et. al. 1992) and 
PRL-PRLR2 (PDB ID: 3ew3; Broutin et. al. 2010). 3-D models were generated, based 
on the created pdb files, using POLYVIEW-3D (Porollo et. al. 2007). 
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Figure 13. Comparison of the hormone binding regions in the extracellular domain of 
known teleost growth hormone receptors (GHR) and of selected prolactin receptors 
(PRLR). Human GHR and human PRLR are used as reference sequences; vertical lines 
extending below or above residues indicate strict conservation of the reference-residue in 
the non-human GHR or non-human PRLR sequences, respectively. The symbols  and 
 indicate a residue that has been conserved between the lamprey sequence and human 
GHR or between the lamprey sequence and human PRLR, respectively. Dashes (-) 
represent gaps that were inserted to maximize alignment; * denote missing sequence. 
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  The structural characteristics of the dimerization domain that allows for the 
rotation of the receptors involved in the dimer, relative to eachother, has been discussed; 
however, the area involved in triggering that rotation is critical to these receptors’ 
biological activity as well. In general, these hormones bind both receptors of the dimer in 
the same general areas of the receptor; these areas, region 1-4, will be examined more 
closely in the context of Figure 9, to be found later in this section. Focusing on binding 
site 2, considering its functional importance, the actual interface between the hormone 
and receptor involves the N-terminus of the hormone and the Gly cavity of the hormone, 
which is essentially a pocket with Gly as the bottom and large amino acids surrounding to 
create the walls of the pocket, and Trp122 (Trp72) of the receptor with the Trp essentially 
filling the pocket. Figure 8 shows strict conservation of this Trp in all species. 
Comparisons of the GHR and PRLR by Broutin et al (2010) indicated that the walls of 
the cavity involve residues of a-helicies 1 and 3 that form a hydrogen bond network with 
residues from the receptor and that these residues in the receptors (GHR or PRLR) are 
topologically similar, but not strictly conserved by amino acid, and not all interacting 
residues are equivalent in the alignment. For example, Ser142 (Asp120 in PRLR) and 
Asp144 (Thr122 in PRLR) are residues involved in this network that are in an equivalent 
position in the alignment. However, Trp122 (GHR) is involved in hydrogen bonding, 
while at a different location in the alignment Glu of PRLR interacts with the same residue 
of the hormone. 
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Figure 14.  Three-dimensional models of the extracellular domains of the truncated 
growth hormone receptor (GHR)/prolactin receptor (PRLR), from sea lamprey, oriented 
to view the binding face of the receptors to illustrate that dimerization and ligand binding 
alter the conformation of the receptors.  In the Upper Panel, center left, the GHR 
homodimer (GHR2) is shown bound to growth hormone (GH; represented, simply, by a 
sphere).  For illustrative purposes, the right-hand monomer is separated (Upper Panel, 
center right) and rotated 90° along the Y-axis (Upper Panel, right) to be in the same 
orientation, in space, as the left-hand monomer (Upper Panel, left).  In the Lower Panel, 
the left-hand and right-hand monomers are enlarged to show that differences in the 
conformations of the receptors are apparent, particularly the orientation of the binding 
regions (regions 1-4; denoted in blue, green, cyan, magenta, respectively) and cysteine 
residues (denoted in yellow). The models were based on deduced protein sequences using 
the SWISS-MODEL workspace (Bordoli and Schwede, 2012) to produce coordinates 
based on the crystal structure of human GH-GHR2 (PBD ID: 3hhr) as template; images 
were generated with POLYVIEW-3D (Porollo and Meller, 2007).   
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 The N-terminus of the hormone and the residue of the receptor with which it 
interacts with, is the other section that makes up site 2. This region of the hormone has 
several interactions with its receptor. Although the N-terminus of both GH and PRL are 
both involved in binding GHR, the amino acids, which are responsible for binding, are 
different between the GH-GHR and PRL-PRLR structures. Asp120 is suspected to be 
involved in the interaction, in PRLR. Pro124, Arg89, Cys140, and Ser142 are believed to 
be involved in binding, in GHR. While some of these interactions show conservation 
(Fig. 13), there is a great deal of difference, in general, when examining regions 1-4. For 
example, Cys140, which is within van der Waals’ distance to Ile of hGh, is strictly 
conserved in the type-1 GHRs but is not seen in any of the type-2 GHRs, just as it is not 
seen in the PRLRs. Indeed, a complete picture of binding can not been see unless 
considering the molecular makeup of the hormones as well, but as evidence seems to 
indicate, the actual residues involved in the interactions that result in binding may be 
variable. Interestingly, site-directed mutagenesis at the functional binding site 2 of GH 
creates a GH antagonist with little to no biological activity, and when recombinantly 
engineered into a homodimer does not only maintain the ability to bind, but does so 
through the use of two site 1’s, one from each of the two GH antagonists involved in the 
homodimer. Furthermore, this homodimer, created using two antagonists, did not share in 
the antagonistic effects of the monomers, but instead acted as an agonist (Langerheim et 
al., 2006). With the ability of GH, PRL, and SL to interchangeably bind with the GHR 
homologues as well as with PRLR homologues, the most notable characteristic of the 
hormone-binding interface on these receptors, then, is not necessarily any particular 
residues, but is the global ability to be versatile in its binding. The hormone binding 
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domain of the lamprey GHBP is shown in Figure 14; with both receptors in the dimer in a 
position to examine the binding domain, the differences between the receptor that binds 
the hormone first and the receptor that binds the hormone second becomes quite apparent, 
supporting the notion that these receptors are plastic in their ability to bind. Returning to 
examine the alignment (Figure 13), some of the most conserved residues in region 1-4 are 
not residues that were found to be involved in interactions with the hormones, they are 
residues such as Ala and Val that are intermittently dispersed in these regions (e.g., 
V142/V121, V146/V125) which would be necessary to allow various residues, that could 
potentially interact with differing ligands, to be free of steric hindrance. Even in region 1, 
where Val is not seen in human, numerous Val residues are intermittently present in this 
part of GHR, in fish species. In summary, both receptors in the dimer bind the hormone 
with the same regions (regions 1-4), but because the binding sites on the hormone are 
located asymmetrically, a major conformational change occurs in the receptor, not upon 
hormone-binding with the initial receptor of the dimer, but upon binding with the second 
as the receptor basically “reaches” to where it can interact with site 2 of the hormone; it is 
this conformational change in the receptor that allows for downstream signaling effects to 
occur and differential degrees of conformational change results in differential signaling.  
 
Summary and conclusions 
 We have isolated a fragment of mRNA from sea lamprey, Petromyzon marinus, 
that we believe is transcribed from the gene that is the evolutionary-precursor to both the 
GHRs and PRLRs thus far characterized in the vertebrate lineage. The structural 
heterogeneity of GHRs results from the existence of multiple genes that arose through a 
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series of gene duplication events during the course of teleost evolution, as well as 
alternative transcripts of a single gene, and the alternative splicing of a single gene 
appears to be conserved in this ancient linage. The evolutionary history of these receptors 
was explored through a phylogenetic analysis that included the characterized protein in 
lamprey, as well as through a microsynteny analysis of candidate genes, in several 
species of fish; evidence supports an orthologous relationship between the Type-1 GHRs 
and GHR lineage that gave rise to humans GHR. Figure 15 illustrates the divergence of 
the GHRs, based on current information. Conclusions of the evolutionary relationships 
are consistent with differences in the structural characteristics of these receptors. We 
suggest that it is plausible, based on our structural assessment, that the lamprey GH and 
PRL both bind to the lamprey GHR/PRLR. Further studies will need to be done to 
confirm that the putative GHBP isolated in this study is, indeed, a soluble binding protein 
able to bind GH.  
 In the past several years, the question of the existence of a distinct “SLR” has 
resided. In an already-unstructured nomenclature system, the system became more 
complex following the characterization of what appeared to be a distinct SL receptor 
(SLR) from masu salmon, based on 125I-SL binding (Fukada et al., 2005) that fell within 
the clade with type 1 GHRs. Recently, Fukamachi and Meyer (2007) suggested that all of 
the teleost type GHR1s should be referred to as SLRs, and that the other major clade 
(type 2 GHRs, which includes the GHR1 and GHR2 of salmonids) be referred to as 
GHRs. The two GHRs of salmonids most likely arose during the more recent 
tetraploidization (4R) event associated with the evolution of this group. Reindl et al. 
(2009) suggested that the binding characteristics observed in masu salmon (Fukada et al., 
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2005) may be a derived trait and that it may be premature to assign the label of “SLR” to 
all type 1 GHRs. Indeed, as will be discussed below, several type 1 GHRs retain GH 
binding characteristics. 
 
Figure 15.  Proposed phylogeny of the growth hormone receptor (GHR) family in 
vertebrates. The divergence of GHRs and prolactin receptors (PRLR) results from a 
series of gene duplication events over the course of vertebrate evolution.  Subsequent 
duplication events in teleosts results in multiple types and subtypes of GHRs in this 
lineage. 
 
 Given the confused state of GHR nomenclature, it is clear that a community-wide 
movement towards a simplified nomenclature system that better represents the 
evolutionary history of this receptor family is needed.  To this end, we suggest a change 
to a system similar to that already adopted for instances of multiple genes.  This system 
utilizes different numbers to designate genes derived from one duplication event, then 
different letters to designate paralogues derived from a subsequent round of duplication.  
In application to GHRs, such a system would use numbers to designate the different GHR 
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types that arose in the actinopterygian lineage (associated with 3R or FSGD); hence, in 
the teleosts there would be GHR1s (we urge abandonment of the term SLR to avoid 
confusion) and GHR2s. The addition of different letters would be added to distinguish 
paralogues associated with 4R duplication events (e.g., salmonids). This will necessitate 
changes to existing names (and some temporary confusion), but we have already done so 
for our GeneBank designations for trout GHRs. So, what were previously referred to as 
rainbow trout GHR1 and GHR2 (which were both in the type 2 GHR clade), are now 
GHR2a and GHR2b, respectively (cf. GenBank accession nos. NM_001124535 and 
NM_001124731).  A similar scheme is proposed for the GHR1s.  Whereas salmonids 
appear to have lost a gene following their 4R event and possess a single GHR1 (GHR 1 is 
proposed to be used in preference to SLR so as to avoid confusion and to better represent 
the evolutionary origins of this gene), other species (e.g., Jian carp, Cyprinus carpio var. 
Jian) retained both GHR1 paralogues, designated GHR1a and GHR1b.  
 There are at least two reasons for not using the term SLR to describe GHR1, 
especially in species other than salmon. First, the binding of GH to eel GHR1 could not 
be displaced by SL (Ozaki et al., 2006). Second, GH, but not SL, activated both seabream 
GHR1 and GHR2 transcription reporter systems (Jiao et al., 2006); discussed in greater 
detail below). In the end, it appears that the ability for these ligands and receptors to 
cross-bind (e.g., GH with PRLR or PRL with GHR) and elicit cellular effects in response 
to cross-binding may be species specific; thus, a nomenclature scheme based of the 
evolutionary relationships of these receptors would be most consistent and would ease the 
learning of any scientist or student new to the conversation of GH biology, which is 
something that should be encouraged.  
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 Through an extensive review of literature on the receptors for GH, PRL, and Sl, and 
the multi-functionality of these hormone (see Ellens and Sheridan, 2012), it is 
theoretically possible to have the divergence of a unique ligand (e.g., somatolactin) by 
neofunctionalization following a gene duplication event, without neofunctionalization of 
a novel/distinct receptor (e.g., somatolactin receptor) if that ligand is able to work 
through an already-functionalized receptor to elicit differential effects; indeed, the 
versatile design of the family of receptors for GH, PRL, and SL, allows for plastic 
binding characteristics and  differential downstream signaling effects. Another possibility 
which would allow for neofunctionalization that results in a new and distinct hormone, 
without a new and distinct receptor with which it operates through, would be a situation 
of herterodimerization of receptors within this family (e.g., a PRLR1-GHR1 dimer). To 
our knowledge, the possibility of herterodimerization of these receptors has never been 
researched in fish, to date. However, placental lactogen (PL), a mammalian-specific 
relative of GH/PRL/SL was shown to have prolonged STAT-1 and STAT-3 
phosphorylation, and thus unique signaling, through binding of a GHR-PRLR 
heterodimer (Biener et al 2003). Similarly, herterodimerization between alternatively-
spliced forms of receptors could, also, serve as a unique receptor for which unique 
signaling events may be transduced. 
 Especially in light of the possibility of novel functions through alternative 
transcripts of a gene or through herterodimerization between different homologues in this 
family of receptors (or herterodimerization between different transcripts of the same or 
different homologue(s), for that matter), hopefully this clarified understanding of the 
evolutionary history of these receptors which reflects the molecular basis of these 
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receptors, will support the continued conversation regarding the molecular basis of 
functionality and how that functionality is transduced to diverse and integrated 
physiological effects in an organism.   
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CONCLUDING REMARKS AND FUTURE DIRECTIONS 
 
General remarks and comments on the future direction of this research  
 With the information gained in this study, there are numerous objectives that 
could yet be done. First and foremost, the presence of this protein, and any alternative 
transcripts, must be confirmed. Gene expression could be determined for this protein, as 
well as any alternative transcripts, through Northern blotting. Western blotting could also 
be used to confirm translation of these transcripts into protein. Another way to 
biologically confirm that the binding protein is indeed a soluble binding protein would be 
through the precipitation of the soluble extracellular domain, while keeping in mind that 
there may be two different binding proteins in existence (one produced by alternative 
splice, the other produced by proteolytic cleavage). Furthermore, the putative GHBP, and 
any full-length receptors that may exist, would have to be confirmed to bind these 
ligands, in order to properly dub these proteins GH-binding protein or GH-receptors. A 
radioreceptor assay, with 125I-labeled hormone, could be done to assess binding and 
establish the kinetics of binding. 
 Through reviewing literature on the topic of GH and GHR, additional points of 
interest, pertinent to the research that has already been done, were discovered which 
should be looked into. First, numerous reports of metal ion interactions with the type-1 
cytokine receptors and their ligands have been reported, most notably for zinc. Although 
zinc is not required for the binding of GH or PRL to their receptors, the binding affinity 
between hGH and hPRLBP was increased about 8000-fold by addition of 50 µM ZnCl2 
(Cunningham et al., 1990). In this particular investigation, the hPRLBP and hGHBP were 
expressed and secreted into the periplasm of Escherichia coli, and binding determined 
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with hGH and hPRL were analyzed. This study indicated that [Zn2+] was required for 
tight binding of hGH to the hPRL receptor but not for binding to the hGH receptor. 
Furthermore, the binding of hGH to hPRLBP, under these conditions, is nearly 100-fold 
stronger than for hPRL and more than 10-fold stronger than the affinity of hGH for one 
hGHBP (Cunningham et al., 1990). These results have been shown to be due to the direct 
interaction between Zn2+, the hormone, and the extracellular receptor (Cunningham et 
al., 1990; Voorhees et al., 2011). To date, the interaction of Zn2+ or any other metal ion 
with these GH-family receptors has not been examined in fish. Finally, the differential 
expression of these ligands, and how multiple genes for GH, PRLR, and SL, affect 
binding and subsequent intracellular signaling must be investigated. To date, most of the 
binding studies on these receptors have not considered that multiple GH genes may be 
differentially expressed in a species-specific manner. With a new understanding of how 
the GHR (and PRLR) can differentially bind a ligand, due to the plastic nature of ligand 
binding in these receptors, to result in differential signaling, it can be concluded that 
different GHs (GH1 and GH2) and the relative amounts of those GHs would likely effect 
results, both in binding assays and in cell signaling studies. Furthermore, other molecular 
variants of hGH have been reported, and summarized by Bustamante et al., (2010); these 
variants include a 24 kDa and 12 kDa glycosylated hGHs, as well as a deamidated hGH 
and phosphorylated hGHs.  Small hGH isoforms (5-kDa and 17-kDa), produced by 
fragmentation of the predominate form of hGH (22 kDa) have also been discovered in 
humans, and stable hGH dimers (a 35 kDa dimer and 45 kDa hGH dimer), as well as 
hGH oligomers have been reported. Differing biological activities were reported in 
response to these GH additional GH variants; some of these variants had increased 
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biological activity, when compared to the 22 kDa hGH form, and others had reduced 
biological activity or were biologically inactive. However, distinct biological activities, 
which regulated only a limited number of metabolic and physiological processes was also 
reported with some of the hGH variants (Bustamante et al., 2010). Thus, in reviewing 
recent literature on the physiological actions of these hormones, is clear that the use of 
hormone from other species in binding assays or studies assessing biological activity 
should be avoided when possible. Not only could differences in the proteins, from one 
species to another, cause differences in binding characteristics or biological activity, but 
the presence of structural variants of these hormones and the relative amounts of the 
variants, if present, could be different from species to species, and could be differentially 
regulated in a species specific manner. 
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